fluorodeoxyglucose f18 has been researched along with Benign Neoplasms, Brain in 694 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (5.04) | 18.7374 |
| 1990's | 129 (18.59) | 18.2507 |
| 2000's | 212 (30.55) | 29.6817 |
| 2010's | 267 (38.47) | 24.3611 |
| 2020's | 51 (7.35) | 2.80 |
| Authors | Studies |
|---|---|
| Cholewiński, W; Kunikowska, J; Marszałek, A; Medak, A; Pietrasz, K; Pietrzak, A; Piotrowski, T; Wojtowicz, J | 1 |
| Glenn, CA; Javan, R; Johnson, DR; Olson, JJ | 1 |
| Nimmagadda, S | 1 |
| Blomqvist, L; Bolin, M; DE Luca, F; Falk Delgado, A; Martin, H; Wassberg, C | 1 |
| Doi, H; Hume, WE; Ishii, A; Mawatari, A; Nakatani, Y; Nozaki, S; Tanaka, M; Tsuyuguchi, N; Wada, Y; Watanabe, Y | 1 |
| Curioni, A; Deandreis, D; Grünig, H; Huellner, MW; Husmann, L; Kotasidis, F; Liberini, V; Mader, C; Maurer, A; Messerli, M; Opitz, I; Orita, E; Pizzuto, DA; Trinckauf, J; Winklhofer, S | 1 |
| Cao, X; Chen, S; Kan, Y; Liao, M; Liao, R; Liu, Z; Nie, L; Tan, D; Xie, M; Yao, R; Zhang, L | 1 |
| Derlon, JM; Gourand, F; Guillouet, S; Kalaeva, D; Khokholova, E; Kobyakov, G; Maryashev, S; Pitskhelauri, D; Postnov, A; Potapov, A; Pronin, I; Pyzhik, E; Rizhova, M; Toutain, J; Usachev, D; Valable, S; Vikhrova, N | 1 |
| Alavi, A; Ayubcha, C; Borja, AJ; Nagaraj, C; Raynor, WY; Revheim, ME; Saini, J; Werner, TJ | 1 |
| Bertaux, M; Cachin, F; Carsin Nicol, B; Chanchou, M; Devillers, A; Farce, J; Girard, A; Le Jeune, F; Le Reste, PJ; Lecouillard, I; Mariano-Goulart, D; Meneret, P; Otman, H; Palard-Novello, X; Vauleon, E | 1 |
| Alavi, A; Hustinx, R; Kumar, R; Withofs, N | 1 |
| Bund, C; Chibbaro, S; Kremer, S; Lersy, F; Namer, IJ | 1 |
| Cao, X; Chen, J; Chen, S; Gao, J; Huang, D; Kan, Y; Li, Y; Liu, Z; Pan, H; Tang, Y; Wang, J; Wang, L; Wen, Z; Xu, X; Zhang, L | 1 |
| Aloglu, M; Atikcan, Ş; Çimen, F; Düzgün, S; Özmen, Ö; Şentürk, A | 1 |
| Bartha, R; Bellyou, M; Desjardins, L; Fox, MS; Hoffman, L; Lee, TY; Li, A; Lim, H; McClennan, A; Qi, Q; Scholl, TJ; Sullivan, R; Thiessen, JD | 1 |
| Arakawa, Y; Fushimi, Y; Hinoda, T; Ikeda, S; Makino, Y; Mineharu, Y; Miyamoto, S; Nakajima, S; Nakamoto, Y; Okuchi, S; Sakata, A; Yoshida, K | 1 |
| Honda, T; Inoue, A; Kanno, K; Kinnami, S; Kitazawa, R; Kunieda, T; Kurata, M; Kusakabe, K; Matsumoto, S; Miyazaki, Y; Ohnishi, T; Shigekawa, S; Suehiro, S; Taniwaki, M; Watanabe, H; Yamashita, D | 1 |
| Chinot, O; Graillon, T; Guedj, E; Horowitz, T; Salgues, B; Tabouret, E; Verger, A | 1 |
| Dai, W; Feng, Y; Liu, Y; Wang, P | 1 |
| Au Yong, TK; Chan, TK; Chu, KS; Kung, BT; Lau, JHY; Li, WI | 1 |
| Li, J; Song, R; Sun, X; Tan, W; Wang, J; Xing, L; Zhang, Y; Zheng, Z | 1 |
| Castellani, M; Castello, A; Crosta, G; Florimonte, L; Pacella, S | 1 |
| Bagul, SD; Basu, S; Chandak, AR; Shelly, D; Singh, BK; Singh, RK; Soni, BK; Sudhan, MD; Verma, P | 1 |
| Cheng, X; Dai, C; Jiang, C; Kong, Z; Li, L; Lin, Y; Liu, D; Liu, Z; Ma, W; Qin, X; Tian, J; Wang, Y | 1 |
| Bund, C; Cicek, AE; Lhermitte, B; Namer, IJ; Proust, F; Ruhland, E | 1 |
| Davidzon, GA; Ellis, JK; Ferri, V; Franc, BL; Iagaru, A; Koran, ME; Nobashi, T; Zacharias, C | 1 |
| Chin, S; Ishida, S; Ishijima, K; Nozaki, M; Shinmei, Y; Yamaguchi, S | 1 |
| Kay, MD; Kuo, PH; Pariury, HE; Perry, A; Winegar, BA | 1 |
| Cheon, GJ; Chung, JH; Kang, KW; Kang, SY; Kim, DW; Kim, HJ; Seo, YS; Wu, HG | 1 |
| Bozzao, A; Carideo, L; Cicone, F; Minniti, G; Scaringi, C; Scopinaro, F; Villani, V | 1 |
| Chae, SY; Huh, JR; Kim, HO; Kim, JH; Kim, JS; Kim, SO; Lee, SH; Oh, JS; Oh, SJ; Ryu, JS; Seo, M | 1 |
| Du, JX; Li, ZG; Liu, K; Zhang, SW; Zhao, Q; Zheng, MY | 1 |
| Hayashi, T; Ikegaya, N; Minamimoto, R; Miyake, Y; Murata, H; Okabe, T; Sasame, J; Tateishi, K; Udaka, N; Utsunomiya, D; Yamamoto, T; Yamanaka, S | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Bertaux, M; Kas, A; Pyatigorskaya, N; Sgard, B; Yahia-Cherif, L | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chen, X; Wang, H; Xue, Q; You, Z; Yuan, J; Zhao, J | 1 |
| Eshghi, N; Garland, LL; Hamilton, RJ; Hsu, C; Kuo, PH; Sawyer, DM; Sawyer, TW | 1 |
| Ball, D; Bressel, M; Bucknell, N; Campbell, BA; David, S; Haghighi, N; Hanna, GG; Kok, D; MacManus, M; Newman, S; Phillips, C; Plumridge, N; Shaw, M; Siva, S; Tran, P; Wheeler, G; Wirth, A | 1 |
| Chiang, GC; Ebani, EJ; Meng, A; Strauss, SB | 1 |
| Beinat, C; Chang, E; Gambhir, SS; Patel, CB; Xie, Y | 1 |
| Malik, D | 1 |
| Cheng, X; Hou, G; Li, F; Wang, P | 1 |
| De Meulenaere, V; De Wever, O; Deblaere, K; Descamps, B; Vanhove, C | 1 |
| Gao, YF; Guan, Y; Hua, W; Kong, Y; Li, SH; Liu, FM; Wen, W; Ye, D; Zhang, J; Zuo, C | 1 |
| Bakhshi, SK; Hasnain, N; Mustafa, RM; Shamim, MS | 1 |
| Cai, J; Lin, Z; Miao, W; Yao, S; Zhang, Y | 1 |
| Bartha, R; Fox, MS; Hoffman, L; Lee, TY; Lim, H; Qi, Q; Scholl, TJ; Thiessen, JD | 1 |
| Alongi, P; Argiroffi, G; Baldari, S; Baratto, L; Bisdas, S; Califaretti, E; Ceci, F; De Vincentis, G; Del Sole, A; Evangelista, L; Frantellizzi, V; Iagaru, A; Laudicella, R; Quartuccio, N | 1 |
| Hatakeyama, J; Oda, M; Ono, T; Shimizu, H; Takahashi, M | 1 |
| Isaka, M; Konno, H; Mizuno, T; Nagata, T; Ohde, Y | 1 |
| Albano, D; Alongi, P; Cistaro, A; Formica, G; Frantellizzi, V; Laudicella, R; Piccardo, A; Pizzuto, DA; Quartuccio, N; Romagnolo, C; Stracuzzi, F | 1 |
| Arora, G; Datta Gupta, S; Kumar, D; Seith Bhalla, A; Shamim, SA; Sikka, K | 1 |
| Jin, G; Li, Y; Su, D | 1 |
| Li, ZG; Mu, HY | 1 |
| Ellis, S; Reader, AJ | 1 |
| Badve, C; Faulhaber, P; Garg, V; Hojjati, M; Rogers, L; Ros, PR; Sloan, A; Tatsuoka, C; Wolansky, LJ | 1 |
| Ai, L; Chen, Q; Dai, J; Fan, D; Jiang, T; Lin, S; Qiao, Z; Wang, K; Zhao, X | 1 |
| Jing, L; Xiaochun, F; Yifan, Z; Yu, P | 1 |
| Arakawa, Y; Fushimi, Y; Miyamoto, S; Okada, T; Togashi, K; Yamamoto, A; Yamauchi, M | 1 |
| Agrawal, A; Gupta, T; Jalali, R; Moiyadi, A; Purandare, NC; Puranik, A; Rangarajan, V; Shah, S; Shetty, P; Shridhar, E | 1 |
| Albano, D; Bertagna, F; Bertoli, M; Bosio, G; Giubbini, R | 1 |
| Pan, Y; Zhang, Y | 1 |
| Bai, HX; Cao, Y; Deng, L; Farwell, MD; Li, H; States, LJ; Sun, J; Tao, Y; Xiao, B; Yang, L; Zhang, P | 1 |
| Burrell, LD; Gillespie, DL; Horn, KP; Jensen, RL; Karsy, M; Yap, JT | 1 |
| Iwasa, H; Kohsaki, S; Miyatake, K; Murata, Y; Nishimori, M; Nogami, M; Tadokoro, M; Ueba, T; Ueba, Y; Yamagami, T | 1 |
| Chi, AS; Cordova, C; Jain, R; Margiewicz, S | 1 |
| Cudalbu, C; Gruetter, R; Hamou, MF; Hegi, ME; Lai, M; Lanz, B; Poitry-Yamate, C; Vassallo, I | 1 |
| Evangelou, E; Nihashi, T; Terasawa, T; Trikalinos, NA | 1 |
| Chang, JH; Kim, D; Kim, S; Kim, SH; Yun, M | 1 |
| Chang, JH; Kim, D; Kim, S; Kim, SH; Park, MA; Yun, M | 1 |
| Fujii, N; Ideguchi, M; Ikeda, E; Ikeda, N; Kimura, T; Nishizaki, T; Ohno, M; Okamura, T; Shimabukuro, T; Suga, K; Tanaka, Y | 1 |
| Aheer, D; Arora, G; Biswas, A; Garg, A; Hazari, PP; Kumar, R; Mishra, AK; Sharma, A; Sharma, P | 1 |
| Itoh, T; Kishida, Y; Maniwa, Y; Nishimura, Y; Ohno, Y; Seki, S; Yoshikawa, T | 1 |
| Andratschke, N; Berghoff, AS; Dummer, R; Frauenfelder, T; Füreder, LM; Kaufmann, PA; Le Rhun, E; Leske, H; Neidert, MC; Petyt, G; Preusser, M; Regli, L; Reyns, N; Roth, P; Rushing, E; Stahel, R; Stupp, R; Weller, M; Wolpert, F | 1 |
| Dağtekin, A; Kara, PÖ; Koç, ZP | 1 |
| Abdollahi, A; Adeberg, S; Afshar-Oromieh, A; Bendszus, M; Bougatf, N; Debus, C; Debus, J; Floca, R; Haberkorn, U; Heiland, S; Knoll, M; Rieken, S; Waltenberger, M; Wick, W | 1 |
| Calvo García, M; García Vicente, AM; Perez-Beteta, J; Soriano Castrejón, A; Villena Martín, M | 1 |
| Merabtene, F; Nataf, V; Prignon, A; Provost, C; Rozenblum-Beddok, L; Talbot, JN | 1 |
| Albano, D; Battistotti, M; Bertagna, F; Bertoli, M; Giubbini, R; Rodella, C; Statuto, M | 1 |
| Ben Bouallègue, F; Mariano-Goulart, D; Menjot de Champfleur, N; Vauchot, F | 1 |
| de Jong, EEC; De Ruysscher, DKM; Dingemans, AC; Gietema, HA; Hendriks, LEL; Hofman, PAM; van Elmpt, W | 1 |
| Kung, HF; Li, N; Liu, F; Xu, X; Yang, J; Yang, Z; Zhang, L; Zhang, Y; Zhu, H; Zhu, L | 1 |
| Bignardi, S; Comelli, A; Ippolito, M; Petrucci, G; Russo, G; Sabini, MG; Stefano, A; Yezzi, A | 1 |
| Achiha, T; Arita, H; Hashimoto, N; Hatazawa, J; Hirata, T; Kagawa, N; Kanemura, Y; Kinoshita, M; Kishima, H; Ogawa, K; Seo, Y; Shimosegawa, E; Suzuki, O; Tamari, K; Teshima, T; Umehara, T; Wakai, N | 1 |
| Cui, R; Sun, H; Wang, J; Zhang, Y | 1 |
| Flors, L; Leiva-Salinas, C; Muttikkal, TJE; Patrie, JT; Puig, J; Rehm, PK; Schiff, D; Sheehan, JP; Wintermark, M | 1 |
| Çermik, TF; Gündoğan, C; Güneş, BY; Yardimci, AH | 1 |
| De Meulenaere, V; De Wever, O; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Leybaert, L; Mollet, P; Neyt, S; Vandeghinste, B; Vanhove, C | 1 |
| Bhatia, A; Grommes, C; Malani, R; Wolfe, J | 1 |
| Masdeu, JC; Pascual, B; Rostomily, RC; Turkheimer, F; Veronese, M; Zanotti-Fregonara, P | 1 |
| Momose, T; Mukasa, A; Soma, T; Takahashi, M; Tanaka, S; Yanagisawa, S | 1 |
| Asa, SL; Cloughesy, TF; Green, RM; Heaney, AP; Kelly, DF; Kim, SSR; Li, JY; Mao, Q; Mareninov, S; McKeever, P; Movassaghi, M; Newell, KL; Qian, J; Rodriguez, FJ; Welsh, CT; Xiong, Z; Yong, WH; Zhang, D | 1 |
| Chiang, GC; Fine, HA; Kovanlikaya, I; Magge, R; Naeger, DM; Pisapia, DJ; Seligman, L | 1 |
| Cho, KG; Jang, SJ; Kim, YI | 1 |
| Carpenter, AB; Chin, BB; Greer, PK; Hansen, L; Hawk, T; Liu, Y; Odion, R; Pirozzi, CJ; Seywald, M; Vaidyanathan, G; Vo-Dinh, T; Waitkus, MS; Yan, H; Yuan, H; Zalutsky, MR; Zhou, Z | 1 |
| Beinat, C; Gambhir, SS; Patel, CB; Xie, Y | 1 |
| He, Q; Luo, G; Shi, X; Yi, C; Yu, D; Zhang, B; Zhang, X | 1 |
| Liu, Z; Maere, C; Sheng, VS; Song, Y; Xu, C; Xue, K; Yang, K | 1 |
| Bootsma, G; de Booij, M; De Ruysscher, D; Dingemans, AM; Hendriks, LEL; Hofman, P; Houben, R; Schoenmaekers, J; Schreurs, W; Westenend, M | 1 |
| Alexiou, GA; Fotopoulos, AD; Jabbour, P; Katsanos, AH; Kyritsis, AP; Sioka, C | 1 |
| Huang, WS; Xu, JH; Yang, M; Zhang, GX; Zheng, Y | 1 |
| Chua, B; Debowski, M; Goodman, S; Jeffree, RL; Lwin, Z; Shaw, TB; Thomas, P | 1 |
| Cheng, X; Kong, Z; Li, J; Li, L; Lin, Y; Liu, Z; Ma, W; Tian, J; Wang, Y; Zhao, D | 1 |
| Choi, JY; Hwang, HS; Kim, BT; Kim, H; Kim, S; Kwon, OJ; Lee, HY; Lee, KS; Shim, YM; Yi, CA | 1 |
| Arakawa, Y; Mikami, Y; Nakajima, S; Okada, T; Togashi, K | 1 |
| Bootsma, GP; Brans, BT; de Ruysscher, DK; Dingemans, AM; Hendriks, LE; Hofman, PA; Scheppers, NA | 1 |
| Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P | 1 |
| Hoh, CK; Kesari, S; Nozawa, A; Rivandi, AH | 1 |
| Cheng, X; Guo, X; Guo, Y; Ma, WB; Wang, RZ; Wang, Y; Zhong, DR | 1 |
| Berkowitz, F; Esposito, G; Nandu, H | 1 |
| Acou, M; D'Asseler, Y; De Ruyck, I; Goethals, I; Kalala, JP; Mertens, K; Van den Broecke, C; Van Hauwe, J | 1 |
| Engelbach, JA; Garbow, JR; Huang, C; Mach, RH; McConathy, J; Piwnica-Worms, D; Rich, KM; Sai, KK; Yuan, L; Zhou, D | 1 |
| Cordeiro, J; Mix, M; Nikkhah, G; Reithmeier, T; Rottenburger, C; Trippel, M | 1 |
| Cook, GJ; Gedela, K; Kulasegaram, R; Lewitschnig, S; Nelson, M; O'Doherty, M; Toby, M | 1 |
| Chen, Z; Liu, Y; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
| Dahabreh, IJ; Nihashi, T; Terasawa, T | 1 |
| Galldiks, N; Langen, KJ | 1 |
| Fougère, Cl; Hutterer, M; Jacobs, AH; Nowosielski, M; Putzer, D; Stockhammer, G; Virgolini, IJ | 1 |
| Fahey, FH; Gururangan, S; Kocak, M; Kun, LE; Ng, SS; Poussaint, TY; Vajapeyam, S; Zukotynski, KA | 1 |
| Hashimoto, K; Kariya, S; Naka, K; Nishizaki, K; Okano, M; Onoda, T; Ooue, T; Yamashita, Y | 1 |
| Kawai, N; Miyake, K; Nishiyama, Y; Tamiya, T; Yamamoto, Y | 1 |
| Faber, C; Jacobs, AH; Kopka, K; Kuhlmann, M; Schäfers, M; Schelhaas, S; Schwegmann, K; Viel, T; Wachsmuth, L; Wagner, S | 1 |
| Beppu, T; Ehara, S; Fujiwara, S; Iwata, R; Kudo, K; Matsuura, H; Ogasawara, K; Sasaki, M; Sasaki, T; Sera, K; Sugai, T; Takai, Y; Terasaki, K; Uesugi, N; Yamada, N | 1 |
| Inoue, T; Kawahara, N; Kubota, K; Minamimoto, R; Murata, H; Nakanowatari, S; Ohtake, M; Suenaga, J; Tateishi, K; Tateishi, U | 1 |
| Wang, J; Zhang, Y; Zhao, C | 1 |
| Iliushchenko, IuR; Kostenikov, NA; Panfilenko, AF; Stanzhevskiĭ, AA; Tiutin, LA | 1 |
| Chang, KH; Choi, SH; Eun, Y; Kang, WJ; Kim, JH; Sohn, CH; Song, YS; Yoon, JH; Yun, TJ | 1 |
| Giovanella, L; Salvatori, M; Treglia, G | 1 |
| Guichard, SM; Keen, HG; Logie, A; Maynard, J; Odedra, R; Ricketts, SA; Shannon, AM; Wedge, SR | 1 |
| Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S | 1 |
| Boada, FE; Davis, DK; Imani, F; Lieberman, FS; Mountz, JM | 1 |
| Augereau, P; Menei, P; Morel, O; Patsouris, A; Paumier, A; Rousseau, A; Tanguy, JY | 1 |
| Cheng, X; Navab, N; Shi, K; Ziegler, SI | 1 |
| Arakawa, Y; Fushimi, Y; Kakigi, T; Kanagaki, M; Mikami, Y; Okada, T; Sakamoto, R; Shimono, T; Takahashi, JC; Togashi, K; Yamamoto, A | 1 |
| Bal, C; Ballal, S; Jain, TK; Karunanithi, S; Sharma, P; Vijay, MK | 1 |
| Antoch, G; Coenen, HH; Filss, CP; Fink, GR; Galldiks, N; Herzog, H; Langen, KJ; Sabel, M; Shah, NJ; Stoffels, G; Turowski, B; Wittsack, HJ; Zhang, K | 1 |
| Bentourkia, M; Blanchette, M; Croteau, É; Lebel, R; Lecomte, R; Lepage, M; Poulin, É; Tremblay, L | 2 |
| Hirata, K; Houkin, K; Kobayashi, H; Kobayashi, K; Manabe, O; Motegi, H; Shiga, T; Terasaka, S; Yamaguchi, S | 1 |
| Hu, X; Li, W; Li, X; Ma, L; Wang, X; Xie, P | 1 |
| Heiss, WD | 1 |
| Bal, C; Julka, PK; Karunanithi, S; Kc, SS; Khangembam, BC; Kumar, R; Sharma, P | 1 |
| Domachevsky, L; Jacene, HA; Kim, CK; Sakellis, CG | 1 |
| Boyett, J; Fahey, F; Fouladi, M; Kocak, M; Kun, L; Poussaint, TY; Treves, T; Vajapeyam, S; Zukotynski, K | 1 |
| Chen, X; Gao, Z; Ji, N; Kang, P; Li, D; Li, F; Liu, Z; Shi, J; Wang, J; Zhang, L; Zhao, X; Zhu, Z | 1 |
| Bradley, KM; Green, AL; Teoh, EJ | 1 |
| Alongi, P; Bomanji, JB; Fraioli, F; Gaze, MN; Groves, AM; Hargrave, D; Hyare, H; Michopoulou, S; Shankar, A; Stoneham, S; Syed, R | 1 |
| Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C | 1 |
| Ciarmiello, A; Gaeta, MC; Giovannini, E; Lazzeri, P; Milano, A | 1 |
| Chatterjee, P; Sharma, P | 1 |
| Asao, T; Fujii, T; Kuwano, H; Morita, H; Tsutsumi, S; Yajima, R; Yamaguchi, S | 1 |
| Jansen, NL; Suchorska, B; Tonn, JC | 1 |
| Feng, Y; Guo, L; Guo, Y; Harris, E; Jiang, W; Shen, S; Wang, Z | 1 |
| Grupe, P; Hess, S; Høilund-Carlsen, PF; Segtnan, EA | 1 |
| Hirata, K; Houkin, K; Kaneko, S; Kobayashi, H; Kobayashi, K; Onimaru, R; Shiga, T; Shirato, H; Tamaki, N; Terasaka, S; Yamaguchi, S | 1 |
| Montagnese, J; Nguyen, N; Rogers, LR; Sher, A; Wolansky, L | 1 |
| Chen, Z; Shi, X; Tang, G; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
| Daldrup-Link, HE; Donig, J; Link, M; Quon, A; Rosenberg, J; Uslu, L | 1 |
| Hattori, N; Hirata, K; Kobayashi, H; Kobayashi, K; Kuge, Y; Magota, K; Manabe, O; Motegi, H; Nishijima, K; Oyama-Manabe, N; Shiga, T; Tamaki, N; Terasaka, S; Yamaguchi, S | 1 |
| Carra, BJ; Clemenshaw, MN | 1 |
| Baxa, J; Ferda, J; Ferdová, E; Hes, O; Mraček, J; Topolčan, O; Tupý, R | 1 |
| Lu, Y | 1 |
| Cincibuch, J; Frysak, Z; Geierova, M; Kaminek, M; Klein, J; Melichar, B; Studentova, H | 1 |
| Abgral, R; Carai, S; Le Roux, PY; Palard, X; Salaün, PY | 1 |
| Hoh, CK; Hoshi, H; Kanematsu, M; Kesari, S; Nozawa, A; Piccioni, D; Rivandi, AH | 1 |
| Alavi, A; Gholami, S; Segtnan, EA | 1 |
| Chen, L; Li, Z; Xu, G; Yu, Y; Zhang, H | 1 |
| Adachi, S; Koizumi, M; Kojo, M; Kubota, K; Matsuno, S; Morioka, N; Nishimura, M; Nishioka, S; Seto, H; Yamamoto, H | 1 |
| Barthel, H; Busse, H; Jochimsen, TH; Kurch, L; Sabri, O; Sattler, B; Schaudinn, A; Schulz, J; Seese, A; Werner, P; Zeisig, V | 1 |
| Barbolosi, D; Battini, S; Faivre, C; Farman-Ara, B; Hapdey, S; Mancini, J; Pacak, K; Taïeb, D | 1 |
| Mena, E; Meoded, A; Solnes, L; Subramaniam, RM; Wray, R | 1 |
| de Nijs, R; Dyssegaard, A; Feng, L; Fischer, W; Guilloteau, D; Jensen, P; Knudsen, GM; Larsen, VA; Law, I; Mikkelsen, JD; Pinborg, LH; Svarer, C; Thomsen, G | 1 |
| Cho, H; Choi, JY; Kim, HK; Kim, J; Lee, HY; Lee, KS; Um, SW | 1 |
| Aaberg-Jessen, C; Andersen, C; Dam, JH; Halle, B; Hvidsten, S; Høilund-Carlsen, PF; Kristensen, BW; Schulz, MK; Thisgaard, H; Thykjær, AS | 1 |
| Dunet, V; Hottinger, A; Nicod-Lalonde, M; Pomoni, A; Prior, JO | 1 |
| Carapella, CM; Chiaravalloti, A; Fabi, A; Floris, R; Marzi, S; Pace, A; Piludu, F; Schillaci, O; Terrenato, I; Vidiri, A; Villani, V | 1 |
| Bette, S; Buchmann, N; Förschler, A; Förster, S; Gempt, J; Meyer, B; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ | 1 |
| Borghammer, P; Haraldsen, A; Hjorthaug, K; Højbjerg, JA; Knap, MM; Kramer, SM; Tietze, A; Zacho, HD | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Asti, M; Cavuto, S; De Berti, G; Erba, PA; Filice, A; Fraternali, A; Froio, A; Iaccarino, C; Iori, M; Pisanello, A; Sghedoni, R; Sollini, M; Versari, A | 1 |
| Borghammer, P; Lassen-Ramshad, Y; Mahajan, A; McGovern, SL; Petersen, JB; Tietze, A | 1 |
| Dankbaar, JW; De Keizer, B; Eppinga, W; Hendrikse, J; Robe, PA; Seute, T; Snijders, TJ | 1 |
| Benzinger, TL; Chicoine, MR; Couture, LE; Dahiya, S; Fouke, SJ; Huang, J; Leeds, HS; Marcus, DS; Massoumzadeh, P; McConathy, J; Raichle, ME; Rich, KM; Su, Y; Tran, DD; Vlassenko, AG | 1 |
| Dostbil, Z; Goya, C; Simsek, FS; Tasdemir, B; Teke, F; Unal, K; Urakci, Z | 1 |
| de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M | 1 |
| Jeong, HJ; Jeong, YJ; Lim, ST; Na, CJ; Sohn, MH | 1 |
| Chen, CL; Chen, NF; Chih-Chuan, H; Li, CC; Li, CZ; Lin, MC; Tang, CT | 1 |
| Aprile, C; Buroni, FE; Lodola, L; Nano, R; Pasi, F; Persico, MG | 1 |
| Beal, K; Gavrilovic, I; Hatzoglou, V; Omuro, A; Peck, KK; Rubel, J; Schneider, T; Ulaner, G; Woo, KM; Yang, TJ; Young, RJ; Zhang, Z | 1 |
| Babb, JS; Fine, H; Golfinos, JG; Jain, R; Kondziolka, D; Lee, J; Raad, RA; Sacconi, B | 1 |
| Bender, B; Buckenmaier, K; Chadzynski, G; Mirkes, C; Scheffler, K; Shajan, G | 1 |
| Chow, PK; Fu, Y; Kee, I; Ong, LC; Ranganath, SH; Wang, CH; Yu, S; Zhan, W; Zheng, L | 1 |
| Bacher-Stier, C; Berndt, M; Bullich, S; Chin, FT; Dinkelborg, LM; Fels, LM; Friebe, M; Gambhir, SS; Gekeler, V; Hoehne, A; Iagaru, AH; Keu, KV; Koglin, N; Kumar, M; Mittra, ES; Moon, DH; Mosci, C; Mueller, A; Schmitt-Willich, H; Stephens, AW | 1 |
| Cabria, M; Garrè, ML; Morana, G; Piccardo, A; Rossi, A | 1 |
| Bal, C; Damle, NA; Taywade, SK | 1 |
| Bouttens, F; D'Haene, N; Du Four, S; Duerinck, J; Everaert, H; Le Mercier, M; Michotte, A; Neyns, B; Salmon, I; Van Binst, AM; Vandervorst, F; Verschaeve, V | 1 |
| Buck, A; Burgos, N; Cardoso, MJ; Delso, G; Huellner, M; Hutton, BF; Ourselin, S; Sekine, T; Ter Voert, EE; Veit-Haibach, P; Warnock, G | 1 |
| Baba, S; Hiwatashi, A; Honda, H; Iihara, K; Isoda, T; Iwaki, T; Kikuchi, K; Kitamura, Y; Kuga, D; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K | 1 |
| Gorgoni, G; Gori, S; Inno, A; Lunardi, G; Pasetto, S; Salgarello, M; Severi, F | 1 |
| Cheng, X; Li, H; Wu, X | 1 |
| Barbarisi, M; Calabria, FF; Cascini, GL; Gangemi, V; Grillea, G | 1 |
| Dunet, V; Prior, JO | 1 |
| Bai, H; Huang, X; Tang, H; Yang, L; Zhou, H | 1 |
| Al-Thaqfi, S; Hadb, A; Naddaf, SY; Syed, GM | 1 |
| Lan, X; Li, J; Qin, C; Sun, X; Wu, Z | 1 |
| de Groot, JF; O'Neill, AF; Qin, L; Van den Abbeele, AD; Wen, PY; Yap, JT | 1 |
| Amiri-Kordestani, L; Balasubramaniam, S; Bates, SE; Bryla, C; Burotto, M; Choyke, P; Davarpanah, N; Figg, WD; Fojo, T; Gonzalez, EM; Liewehr, DJ; Lindenberg, M; O'Sullivan, CC; Patronas, N; Peer, CJ; Steinberg, SM | 1 |
| Cazes, A; Combaret, V; Delattre, O; Janoueix-Lerosey, I; Montravers, F; Prignon, A; Provost, C; Talbot, JN | 1 |
| Hattori, N; Hirata, K; Ito, YM; Kobayashi, H; Kobayashi, K; Kuge, Y; Manabe, O; Shiga, T; Tamaki, N; Tanaka, S; Terasaka, S; Toyonaga, T; Watanabe, S; Yamaguchi, S | 1 |
| Anees K, M; Jayaprakash, PG; Joy, A; Madhavan, J; Nair, S; Nanabala, R; Pillai, MR; Sasikumar, A | 1 |
| Herholz, K | 2 |
| Hatzoglou, V; Omuro, A; Ulaner, G; Yang, TJ; Young, RJ | 1 |
| Albert, NL; Cicone, F; Filss, CP; Galldiks, N; Langen, KJ; Minniti, G; Prior, JO; Scopinaro, F | 1 |
| Chan, M; Hsiao, E | 1 |
| Busk, M; Frøkiær, J; Horsman, MR; Jakobsen, S; Munk, OL; Overgaard, J | 1 |
| Arai, T; Koyama, K; Momose, T; Mukasa, A; Soma, T; Takahashi, M | 1 |
| Flors, L; Leiva-Salinas, C; Patrie, JT; Rehm, PK; Schiff, D | 1 |
| Basher, RK; Bhatia, A; Jain, TK; Mittal, BR; Prakash, G; Sood, A | 1 |
| Carames, MA; Carreras, JL; Clavo, B; Montz, R; Otermin, E; Robaina, F | 1 |
| Chung, JK; Jeong, JM; Jung, HW; Kim, DG; Lee, DS; Lee, HY; Lee, MC | 1 |
| Ameshima, S; Demura, Y; Ishizaki, T; Mizuno, S; Morikawa, M; Okazawa, H | 1 |
| Hatakeyama, T; Kaji, M; Kameyama, R; Kawai, N; Kimura, N; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Imahori, Y; Kajimoto, Y; Kawabata, S; Kirihata, M; Kuroiwa, T; Miyashita, M; Miyatake, S; Ono, K; Otsuki, Y; Shibata, MA; Yokoyama, K | 1 |
| Barrie, M; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Metellus, P; Mundler, O | 1 |
| Fischman, AJ | 1 |
| Angotti, F; Marano, GD; Palumbo, B | 1 |
| Airley, R; Barnett, C; Bottomly, M; Brock, C; Charnley, N; Du Plessis, D; Matthews, J; Price, P; Swindell, R; Symonds, K; West, C | 1 |
| Hahn, CA; Hollis, D; Kirkpatrick, J; Light, K; Marks, LB; Raynor, R; Shafman, T; Tisch, A; Turkington, T; Wong, T; Zhou, SM | 1 |
| Kitajima, K; Nakamoto, Y; Okizuka, H; Onishi, Y; Senda, M; Suganuma, N; Sugimura, K | 1 |
| Britz-Cunningham, SH; Gerbaudo, VH; Millstine, JW | 1 |
| Havlioglu, N; Hueser, CN; Nguyen, NC; Osman, M; Patel, AJ | 1 |
| Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S; Voulgaris, S | 1 |
| Akduman, EI; Nguyen, NC; Oliver, D; Osman, MM; Sayed, MH | 1 |
| Hashimoto, I; Kamada, H; Kato, N; Moriyama, K; Murakami, H; Nakasato, M; Nishihara, H; Sawa, H; Tanaka, S; Yamamoto, D | 1 |
| Fong, D; Wong, ST; Yuen, SC | 1 |
| Butler-Henderson, K; Campbell, A; Lenzo, NP; McCarthy, M; Yuan, JB | 1 |
| Abrey, LE; Deangelis, LM; Mohile, NA | 1 |
| Aoyagi, M; Inaji, M; Kawano, Y; Maehara, T; Nakagawa, K; Nariai, T; Ohno, K; Tamaki, M; Toriyama, H | 1 |
| Henderson, R; Ho, LT; Seto, J; Wassef, H | 1 |
| Chung, JK; Kang, KW; Lee, DS; Lee, JW; Lee, MC; Lee, SM; Paeng, JC; Park, SH | 1 |
| D'Souza, M; Jaimini, A; Jain, N; Kaur, P; Mondal, A; Sharma, R; Singh, D; Singh, N; Tripathi, M | 1 |
| Bailly, P; Brulon, V; Comtat, C; Meyer, ME; Trébossen, R | 1 |
| Carames, MA; Carreras, JL; Clavo, B; Hernandez, MA; Lloret, M; Montz, R; Ponce, P; Robaina, F | 1 |
| Almubarak, S; Gan, YC; Goddard, K; Hendson, G; Hukin, J; Nadel, H; Poskitt, K; Steinbok, P | 1 |
| Carpentieri, DF; Chen, K; Dickman, PS; Etzl, MM; Irving, A; Kaplan, AM; Kruer, MC; Mathieson, K | 1 |
| Hatakeyama, T; Kameyama, R; Kawai, N; Kimura, N; Nishiyama, Y; Yamamoto, Y | 1 |
| Cai, L; Chen, QS; Gao, S; Li, DC; Li, YS; Xing, XL | 1 |
| Allard, M; Farid, K; Fernandez, P; Guyot, M; Jeandot, R; Sibon, I | 1 |
| Jobst, BC | 1 |
| Boy, C; Buell, U; Coenen, HH; Eble, MJ; Ehmer, J; Kaiser, HJ; Piroth, MD; Schaefer, WM; Thiele, F | 1 |
| Bachofner, A; Coenen, HH; Floeth, FW; Hamacher, K; Herzog, H; Jansen, P; Langen, KJ; Pauleit, D; Reifenberger, G; Sabel, M; Stoffels, G; Tellmann, L | 1 |
| Evanson, J; Kelly, PA; Metcalfe, K; Monson, JP; Plowman, PN; Sabin, I | 1 |
| Warren, KE | 1 |
| Kotzerke, J; Nestle, U | 1 |
| Buchegger, F; Casanova, N; Dipasquale, G; Miralbell, R; Nouet, P; Ratib, O; Rouzaud, M; Vees, H; Weber, DC; Zilli, T | 1 |
| Cho, ZH; Gu, SH; Jang, DP; Kang, BT; Kim, DY; Kim, YB; Park, C; Park, HM; Woo, EJ; Yoo, JH | 1 |
| Higano, S; Iwata, R; Kanamori, M; Kumabe, T; Saito, R; Shibahara, I; Sonoda, Y; Takai, Y; Takanami, K; Tominaga, T; Watanabe, M | 1 |
| Amador, R; Galeano, I; Lucas, A; Martín, M; Martínez, JC; Prat, R; Reynés, G | 1 |
| Dicker, DT; Dorsey, JF; Dowling, ML; El-Deiry, WS; Kao, GD; Mintz, A; Plastaras, JP; Tian, X | 1 |
| Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE | 1 |
| Ament, C; Gonzalez, RG; Hochberg, FH; Kwong, K; Lev, MH; Mullins, ME; Ozsunar, Y; Schaefer, PW | 1 |
| Hasegawa, T; Houkin, K; Minamida, Y; Momota, H; Noguchi, H; Suzuki, K; Tonooka, A; Wanibuchi, M; Yamamoto, K | 1 |
| Haylock, B; Husband, D; Jenkinson, MD; Pietronigro, D; Shenoy, A; Smith, TS; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R | 1 |
| Beattie, BJ; Blasberg, RG; Holodny, AI; Makeyev, S; Riad, S | 1 |
| Aukema, TS; Bonfrer, JM; Korse, CM; Kroon, BB; Nieweg, OE; Olmos, RA; Vogel, WV; Wouters, MW | 1 |
| Bhojani, MS; Chenevert, TL; Galbán, CJ; Johnson, TD; Koeppe, RA; Kuszpit, KK; Lee, KC; Meyer, CR; Moffat, BA; Ranga, R; Rehemtulla, A; Ross, BD; Van Dort, ME | 1 |
| Mittal, S; Oni-Orisan, A; Shah, AK; Stenz, J | 1 |
| Balogova, S; Giannesini, C; Gutman, F; Huchet, V; Izrael, V; Kerrou, K; Muresan, IP; Nataf, V; Pene, F; Prignon, A; Schlienger, M; Talbot, JN | 1 |
| Gidding, CE; Gilles, R; Janssens, GO; Oyen, WJ; van der Vliet, TM; Vogel, WV | 1 |
| Cho, BK; Kim, SK; Lee, DS; Lee, HS; Lee, J; Lee, JY; Paeng, JC; Park, SH; Phi, JH; Wang, KC | 1 |
| Ben-Levi, E; Naidich, JJ; Nguyen, VT; Palestro, CJ; Rini, JN; Yi Li, J | 1 |
| Aigner, RM; Dunzinger, A; Nussbaumer, K; Pichler, J; Pichler, R; Topakian, R; Weis, S; Wurm, G | 1 |
| Aukema, TS; Klop, WM; Kroon, BB; Nieweg, OE; Valdés Olmos, RA; Vogel, WV; Wouters, MW | 1 |
| Brotchi, J; Goldman, S; Levivier, M; Lubansu, A; Massager, N; Pirotte, BJ; Van Bogaert, P; Wikler, D | 2 |
| Glass, JO; Mateja, SJ; Reddick, WE; Shan, ZY; Shulkin, BL | 1 |
| Beer, AJ; Drzezga, A; Kläsner, BD; Krause, BJ | 1 |
| Jung, SA; Kim, CG; Kim, DW; Park, SA | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F | 1 |
| Mineura, K; Miyamoto, J; Owada, K; Sasajima, H | 1 |
| Hirata, K; Kobayashi, H; Murata, J; Shiga, T; Tanaka, S; Terasaka, S; Yamaguchi, S | 1 |
| Chang, KH; Jung, HW; Kang, KW; Kim, YH; Lee, SH; Lim, YJ; Oh, SW; Park, CK | 1 |
| Asaoka, K; Hirata, K; Kobayashi, H; Kubota, K; Murata, J; Narita, T; Shiga, S; Tanaka, S; Terasaka, S; Usui, R; Yamaguchi, S | 1 |
| Chan, WS; Khong, PL; Zhang, J | 1 |
| Bognar, L; Borbely, K; Fedorcsak, I; Kasler, M; Martos, J; Wintermark, M | 1 |
| Baumert, BG; Borger, J; De Ruysscher, D; Lambin, P; Lammering, G; Lutgens, L; Ollers, M; van Baardwijk, A; van den Ende, P | 1 |
| Franzius, C | 1 |
| Burkholder, I; Combs, SE; Essig, M; Giesel, FL; Haberkorn, U; Henze, M; Kauczor, HU; Kroll, A; Meissner, M; Stieltjes, B; Tüttenberg, J; Vogt-Schaden, M; Weber, MA; Zimmer, F; Zoubaa, S | 1 |
| Drappatz, J; Gerbaudo, VH; Horky, LL; Hsiao, EM; Weiss, SE | 1 |
| Brown, PD; Buckner, JC; Galanis, E; Giannini, C; Jaeckle, KA; McGraw, S; Peller, PJ; Sarkaria, JN; Uhm, JH; Wu, W | 1 |
| Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L | 1 |
| Barboriak, DP; Friedman, HS; Paldino, MJ; Reardon, DA; Wong, TZ | 1 |
| Akamatsu, H; Endo, M; Kaira, K; Murakami, H; Naito, T; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Boada, FE; Davis, DK; Deeb, EL; Imani, F; Lieberman, FS; Mountz, JM | 1 |
| Buck, AK; Frechen, D; Kley, H; Krüger, S; Maschke, S; Mottaghy, FM; Pauls, S; Reske, SN; Wibmer, T | 1 |
| Ellison, DW; Löbel, U; Patay, Z; Shulkin, BL | 1 |
| Avila, EK; Gutin, PH; Lassman, AB; Morris, PG; Rosenblum, MK | 1 |
| Cheng, YK; Hsiao, IT; Lin, KJ; Wang, TC; Wey, SP; Yen, TC | 1 |
| Goldman, S; Pirotte, BJ | 1 |
| Bal, C; Julka, PK; Kumar, A; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
| Añaños, M; Calvo, N; Danús, M; Intriago, B; Montero, M; Trampal, C | 1 |
| Akter, M; Hirai, T; Iwashita, K; Kitajima, M; Kuratsu, J; Makino, K; Murakami, R; Nakamura, H; Nakashima, R; Shigematsu, Y; Shiraishi, S; Uetani, H; Yamashita, Y | 1 |
| Horky, LL; Treves, ST | 1 |
| Aki, T; Asano, Y; Ito, T; Iwama, T; Miwa, K; Shinoda, J; Takenaka, S; Yokoyama, K | 1 |
| Chiu, JS; Hung, GU; Kao, CH; Pei, YL; Yang, SK | 1 |
| Amin, M; Chunta, JL; Marples, B; Martinez, AA; Oliver Wong, CY; Park, SS; Robertson, JM; Wilson, GD | 1 |
| Dianchao, Y; Weian, C; Xiangsong, Z; Xiaoyan, W; Xiongchong, S; Zhifeng, C | 1 |
| Arbizu, J; Aristu, JJ; Díez-Valle, R; Domínguez-Prado, I; Garrastachu, P; Martí-Climent, JM; Peñuelas, I; Prieto, E; Tejada, S | 1 |
| Eberl, S; Feng, DD; Fulham, M; Wen, L; Xia, Y | 1 |
| Bal, C; Julka, PK; Kumar, R; Malhotra, A; Santra, A; Sharma, P | 1 |
| Cabezon, A; Carreras, JL; Catala, L; Clavo, B; Fiuza, D; Hernandez, MA; Jorge, IJ; Jover, R; Perez, JL; Robaina, F; Valcarcel, B | 1 |
| Bandiera, A; Bolognesi, A; Carretta, A; Ciriaco, P; Franzin, A; Gregorc, V; Melloni, G; Picozzi, P; Viganò, M; Zannini, P | 1 |
| Heiss, WD; Lanfermann, H; Raab, P | 1 |
| Arita, H; Fujimoto, Y; Goto, T; Hashimoto, N; Hatazawa, J; Isohashi, K; Kagawa, N; Kinoshita, M; Kishima, H; Okita, Y; Saitoh, Y; Shimosegawa, E; Yoshimine, T | 1 |
| Fadeev, NP; Golovtsova, MIu; Kartashev, AV; Kostenikov, NA; Tiushin, LA; Zykov, EM | 1 |
| Domínguez, ML; Durán, C; García, L; Infante, JR; Rayo, JI; Sánchez, R; Serrano, J | 1 |
| Chen, L; Guan, Y; Lin, X; Tan, H | 1 |
| Chan, C; Guha, A; Houle, S; McLarty, K; McLaurin, J; Moran, MD; Mukherjee, J; Nitz, M; Reilly, RM; Sabha, N; Scollard, DA; Vasdev, N; Wilson, AA | 1 |
| Burger, IA; Hany, TF; Schmid, DT | 1 |
| Barrie, M; Béquet-Boucard, C; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Mancini, J; Metellus, P; Mundler, O | 1 |
| Bal, J; Jaimini, A; Jain, J; Kumar, N; Mishra, AK; Mondal, A; Pandey, S; Sharma, R; Souza, MM; Tripathi, M; Varshney, R | 1 |
| D'Souza, MM; Garg, N; Jaimini, A; Monndal, A; Sharma, R; Tripathi, M; Tripathi, RP | 1 |
| Díaz-Fernández, ML; Fuertes, J; Intriago, B; Mestre-Fusco, A; Suárez-Piñera, M; Trampal, C; Wessling, H | 1 |
| Liu, JG; Liu, XS; Ma, L; You, C | 1 |
| Choi, KH; Choi, SS; Kim, HS; Kim, TY; Park, SA; Yang, CY | 1 |
| Goethals, I; Lambert, B; Mees, G; Mertens, K; Van de Wiele, C | 1 |
| Barrie, M; Bequet-Boucard, C; Chinot, O; Colavolpe, C; Figarella-Branger, D; Guedj, E; Mancini, J; Metellus, P; Mundler, O; Tabouret, E | 1 |
| Liao, G; Mao, L; Wang, H; Xie, G; Zhang, N | 1 |
| Houkin, K; Kamoshima, Y; Kaneko, S; Kobayashi, H; Kubota, K; Tanaka, S; Terasaka, S | 1 |
| Ishida, T; Kunimasa, K; Masuda, G; Watanabe, N | 1 |
| Hatakeyama, T; Kawai, N; Miyake, K; Okada, M; Shinomiya, A; Tamiya, T | 1 |
| Chierichetti, F; Pizzolato, G | 1 |
| Gulyás, B; Halldin, C | 1 |
| Angelidis, G; Georgoulias, P; Leondi, A; Psimadas, D; Valotassiou, V | 1 |
| Burger, R; Held, P; Rohlfs, AK; Römer, FW; Strutz, J; Viebahn, C; Woenckhaus, M | 1 |
| Alkonyi, B; Bahl, G; Barger, GR; Chakraborty, PK; Chugani, DC; Juhász, C; Kupsky, WJ; Mittal, S; Muzik, O; Robinette, NL | 1 |
| Achten, E; Acou, M; Goethals, I; Mertens, K; Nuyts, R; Van den Broecke, C; Van Roost, D | 1 |
| Backes, H; Bjerkvig, R; Brekka, N; Hoehn, M; Jacobs, AH; Jikeli, JF; Miletic, H; Monfared, P; Neumaier, B; Niclou, SP; Stieber, D; Talasila, KM; Tavitian, B; Thorsen, F; Viel, T; Waerzeggers, Y; Wang, J; Winkeler, A | 1 |
| Bent, RS; Herscovitch, P; Hipp, SJ; Patronas, N; Solomon, JM; Steffen-Smith, EA; Steinberg, SM; Warren, KE | 1 |
| Li, C; Li, P; Qian, Y; Shi, Y; Wu, H; Wu, Y; Yang, J; Zhang, H; Zhang, J | 1 |
| Asklund, T; Axelsson, J; Johansson, A; Karlsson, M; Larsson, A; Nyholm, T; Riklund, K | 1 |
| Abe, K; Hiwatashi, A; Honda, H; Iwaki, T; Kikuchi, K; Maruoka, Y; Mizoguchi, M; Suzuki, SO; Togao, O; Yamashita, K; Yoshimoto, K; Yoshiura, T | 1 |
| Belka, C; Büsing, K; Eigenbrod, S; Ganswindt, U; Geisler, J; Jansen, N; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB | 1 |
| Allende-Riera, A; Cabello-García, D; Cárdenas-Negro, JC; De Sequera-Rahola, M; Martínez-Gimeno, E; Muñoz-Iglesias, J; Ochoa-Figueroa, MA; Uña-Gorospe, J | 1 |
| Harari, PM; Jeraj, R; Nyflot, MJ; Perlman, SB; Yip, S | 1 |
| Bourgeat, P; Coulthard, A; Crozier, S; Dowson, N; Fay, M; Gal, Y; Rose, S; Salvado, O; Thomas, P | 1 |
| Bartenstein, P; Cumming, P; Egensperger, R; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; Kretzschmar, HA; la Fougère, C; Lutz, J; Pöpperl, G; Schwartz, C; Thon, N; Tonn, JC | 1 |
| Barré, L; Bernaudin, M; Corroyer-Dulmont, A; Delamare, J; Divoux, D; Guillamo, JS; Ibazizène, M; Jacobs, AH; Lecocq, M; MacKenzie, ET; Pérès, EA; Petit, E; Roussel, S; Toutain, J; Valable, S; Varoqueaux, N | 1 |
| Campos, C; Carlin, SD; Cheal, SM; Doran, MG; Evans, MJ; Holland, JP; Lewis, JS; Mellinghoff, IK; Rice, SL; Sawyers, CL | 1 |
| Hoffman, JM; Kadrmas, DJ; Rust, TC | 1 |
| Göbel, G; Hutterer, M; Jacobs, AH; Jansen, NL; la Fougère, C; McCoy, M; Nowosielski, M; Putzer, D; Schocke, M; Seiz, M; Stockhammer, G; Trinka, E; Virgolini, IJ | 1 |
| Hanzawa, H; Hatano, T; Kuge, Y; Kuno, N; Nishijima, K; Sakamoto, T; Tamaki, N; Zhao, S; Zhao, Y | 1 |
| Castiglioni, I; Di Grigoli, G; Gallivanone, F; Gilardi, MC; Górriz, JM; Grosso, E; López, M; Moresco, R; Ramírez, J; Salvatore, C; Valtorta, S | 1 |
| Bal, C; Bandopadhyaya, GP; Damle, NA; Kumar, L; Kumar, P; Lata, S; Malhotra, A | 1 |
| Kawai, N; Miyake, K; Nishiyama, Y; Okada, M; Tamiya, T; Yamamoto, Y | 1 |
| Gildehaus, FJ; Götz, C; Hahn, K; Pöpperl, G; Reulen, HJ; Tatsch, K; Yousry, TA | 1 |
| Fazekas, F; Payer, F | 1 |
| Wienhard, K | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
| Borrego Dorado, I; Vázquez Albertino, R | 1 |
| Harila-Saari, A; Jyrkkiö, S; Kalimo, H; Laine, J; Mäkipernaa, A; Metsähonkala, L; Minn, H; Någren, K; Pihko, H; Salmi, TT; Utriainen, M; Utriainen, T | 1 |
| Blake, M; Bushnell, D; Graham, MM; Johnson, J; Juweid, ME; Madsen, M; Menda, Y; O'Dorisio, MS | 1 |
| Buell, U; Gilsbach, JM; Hans, FJ; Krings, T; Meyer, PT; Möller-Hartmann, W; Reinges, MH; Rohde, V; Sabri, O; Schreckenberger, M; Spetzger, U; Thron, A | 1 |
| Chung, JK; Jeong, HJ; Jeong, JM; Jung, HW; Kim, CY; Kim, DG; Kim, YK; Lee, DS; Lee, MC | 1 |
| Højgaard, L; Klee, B; Kosteljanetz, M; Law, I | 1 |
| Douglas, JG; Hummel, S; Krohn, KA; Mankoff, DA; Rostomilly, R; Rostomily, RC; Scharnhorst, J; Silbergeld, DL; Spence, AM; Stelzer, KJ; Tralins, KS | 1 |
| Belohlávek, O; Kantorová, I; Liscák, R; Novotný, J; Simonová, G | 1 |
| Husso-Saastamoinen, M; Kuikka, JT; Sohlberg, A | 1 |
| Buck, A; Kamel, E | 1 |
| Barboriak, DP; Coleman, RE; Provenzale, JM; Rohren, EM | 1 |
| Momose, T | 3 |
| Steinert, HC; von Schulthess, GK | 1 |
| Bingham, JB | 1 |
| Liu, HG; Mountz, JM | 1 |
| Coleman, RE; van der Westhuizen, GJ; Wong, TZ | 1 |
| Franzius, C; Schober, O | 1 |
| Bénard, F; Hustinx, R; Romsa, J | 1 |
| Andersen, PB; Holm, S; Krabbe, K; Laursen, H; Leffers, AM; Müller, JR; Paulson, OB; Schmiegelow, M | 1 |
| Hatazawa, J; Higuchi, I; Nakamura, H | 1 |
| Cheng, X; Dang, YH; Wang, SZ; Zhou, Q | 1 |
| Dittmar, C; Garlip, G; Heiss, WD; Jacobs, AH; Winkeler, A | 1 |
| Bossuyt, A; Caveliers, V; Everaert, H; Franken, PR; Lahoutte, T; Mertens, J | 1 |
| Bernstein, T; Christian, B; Dunigan, K; Hwang, DR; Jacobs, M; Kraus, G; Mantil, JC; Padma, MV; Ruppert, J; Said, S; Satter, M | 1 |
| Beattie, B; Blasberg, R; Dasai, R; Finn, R; Miyagawa, T; Oku, T; Sasajima, T; Tjuvajev, JG | 1 |
| Granov, AM; Kostenikov, NA; Ryzhkova, DV; Savello, VE; Stanzhevskiĭ, AA; Tiushin, LA; Tlostanova, MS | 1 |
| Carrasquillo, JA; Chen, CC; Dunleavy, K; Nguyen, JD | 1 |
| Endo, K; Higuchi, T; Oriuchi, N; Tian, M; Zhang, H | 1 |
| Borbély, K | 1 |
| Chung, JK; Jeong, JM; Kim, SK; Lee, DS; Lee, MC; Lee, YJ | 1 |
| Coit, DG; Wong, SL | 1 |
| Brink, I; Digel, W; Ghanem, N; Henke, M; Mix, M; Moser, E; Nitzsche, EU; Ruhland, S; Schumacher, T; Stoelben, E | 1 |
| Brotchi, J; David, P; Goldman, S; Levivier, M; Massager, N; Pirotte, B; Salmon, I; Vandesteene, A; Wikler, D | 1 |
| Bormans, G; Ceyssens, S; de Groot, T; Flamen, P; Menten, J; Mortelmans, L; Van Calenbergh, F; Van Laere, K | 1 |
| Chung, JK; Im, SH; Jeong, JM; Jung, HW; Kim, DG; Kim, S; Lee, DS; Lee, MC | 1 |
| Cinotti, LE; Frappaz, D; Giammarile, F; Guyotat, J; Honnorat, J; Jouanneau, E; Jouvet, A; Le Bars, D; Pelissou-Guyotat, I; Ramackers, JM; Saint Pierre, G; Setiey, A; Thiesse, P | 1 |
| Bachert, P; Henze, M; Kauczor, HU; Lichy, MP; Plathow, C; Schlemmer, HP | 1 |
| Brotchi, J; David, P; Goldman, S; Levivier, M; Lipszyc, M; Massager, N; Pirotte, B; Salmon, I; Wikler, D | 1 |
| Hayashi, S; Hisada, K; Kamisaki, Y; Kato, H; Kishida, M; Matsunari, I; Noguchi, K; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Bossuyt, A; De Mey, J; Everaert, H; Franken, PR; Lahoutte, T; Muylle, K | 1 |
| Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Mankoff, DA; Minoshima, S; Muzi, M; O'Sullivan, SF; Pham, P; Spence, AM; Swanson, K | 1 |
| Chen, LH; Chen, YR; Li, WX; Lin, YR | 1 |
| Kawai, N; Masada, T; Matsumoto, Y; Nagao, S; Tamiya, T | 1 |
| Alavi, A | 1 |
| Greenstein, EA; Tikofsky, RS; Van Heertum, RL | 1 |
| Aguzzi, A; Buck, A; Hermann, DM; Kaser-Hotz, B; Lutz, A; Pahnke, J; Radovanovic, I; Scheidegger, S; Spaeth, N; Verwey, J; Weber, B; Weishaupt, D; Westera, G; Wild, D; Wyss, MT | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitski, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Agazaryan, N; Dahlbom, M; Goss, BW; Lee, SP; Solberg, TD | 1 |
| Momose, T; Ohtomo, K; Takao, H | 1 |
| Branle, F; Brotchi, J; De Witte, O; Goldman, S; Oulad Ben Taib, N; Rorive, S | 1 |
| Barthel, H; Kendziorra, K; Meixensberger, J; Sabri, O; Schober, R; Winkler, D; Zimmer, C | 1 |
| Belhocine, T; Brink, I; De Deyn, PP; Flamen, P; Roland, J; Van der Borght, T; Weiner, SM | 1 |
| Alavi, A; Hustinx, R; Kaschten, B; Pourdehnad, M | 1 |
| Goldman, S; Levivier, M; Massager, N; Wikler, D | 1 |
| Boethius, J; Hautanen, K; Kraepelien, T; Lippitz, BE; Rähn, T; Ritzling, M; Ulfarsson, E | 1 |
| Lewis, PJ; Siegel, A; Siepmann, DB | 1 |
| Adineh, M; Bidwell, K; Dunigan, K; Ezzeddine, B; Mantil, J; Mukherjee, J; Padma, MV; Pugar, K; Satter, M; Shi, B | 1 |
| Börner, AR; Knapp, WH; Mirzayan, MJ; Petrich, T; Samii, A; Samii, M | 1 |
| Baleriaux, D; Brotchi, J; David, P; Detemmerman, D; Goldman, S; Levivier, M; Morelli, D; Pirotte, B; Van Bogaert, P | 1 |
| Lengyel, Z; Molnar, P; Novak, L; Tron, L | 1 |
| Brock, CS; Jones, T; Luthra, SK; Osman, S; Price, PM; Young, H | 1 |
| Borgwardt, L; Carstensen, H; Højgaard, L; Laursen, H; Nowak, M; Schmiegelow, K; Thomsen, C | 1 |
| Chang, CW; Chen, JC; Hwang, JJ; Hwang, LC; Lee, TW; Liu, RS; Wang, HE; Wu, SY | 1 |
| Armand, JP; Beaudre, A; Bidault, F; Bruna, A; Dhermain, F; Ducreux, D; Haie-Meder, C; Parker, F; Roujeau, T | 1 |
| Bergsneider, M; Chen, W; Cloughesy, T; Czernin, J; Kamdar, N; Liau, L; Mischel, P; Phelps, ME; Satyamurthy, N; Silverman, DH | 1 |
| Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
| Bobek-Billewicz, B; Jurkowski, MK; Romanowicz, G | 1 |
| Ell, PJ | 2 |
| Chahlavi, A; Staugaitis, SM; Vogelbaum, MA; Yahya, R | 1 |
| Gildehaus, FJ; Goetz, C; Herms, J; Holtmannspötter, M; Koch, W; Kreth, FW; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC | 1 |
| Kawai, N; Kawanishi, M; Nagao, S; Tamiya, T | 1 |
| Ghodsian, M; Hyde, CC; Obrzut, SL; Schiepers, C; Watts, WJ | 1 |
| Douglas, JG; Krohn, KA; Mankoff, DA; Muzi, M; Rostomily, RC; Scharnhorst, J; Silbergeld, DL; Spence, AM; Stelzer, KJ; Tralins, KS | 1 |
| Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; Spence, AM | 1 |
| Chang, CP; Chang, CW; Chu, LS; Chu, YK; Hsieh, HJ; Huang, MC; Liao, SQ; Liu, RS; Yang, BH; Yeh, SH; Yen, SH | 1 |
| Kawai, N; Miyake, K; Nagao, S; Nishiyama, Y; Tamiya, T | 1 |
| Debus, J; Eisenhut, M; Haberkorn, U; Henze, M; Hipp, P; Mier, W; Ozdemir-Sahin, N | 1 |
| Boethius, J; Ericson, K; Wang, SX | 1 |
| Ben Taib, NO; Brotchi, J; David, P; Dewitte, O; Goldman, S; Lefranc, F; Levivier, M; Massager, N; Pirotte, B; Rorive, S; Wikler, D | 1 |
| Berlangieri, SU; Cher, LM; Fabinyi, G; Hannah, A; Lawrentschuk, N; Murone, C; O'Keefe, GJ; Papenfuss, A; Ramdave, S; Sachinidis, JI; Scott, AM | 1 |
| Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT | 1 |
| Brashears, J; Coleman, RE; Friedman, A; Friedman, HS; Gururangan, S; Halperin, EC; McLaughlin, CA; Provenzale, J; Quinn, J; Reardon, D; Vredenburgh, J; Watral, MA | 1 |
| Borbély, K; Ericson, K; Gulyás, B; Nyáry, I; Tóth, M | 1 |
| Carames, MA; Carreras, JL; Clavo, B; Domper, M; Hernandez, MA; Montz, R; Morera, J; Pinar, B; Robaina, F; Santullano, V | 1 |
| Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Rommel, F; Sabel, M; Stoffels, G; Stummer, W | 1 |
| Andersen, PB; Blinkenberg, M; Kosteljanetz, M; Lassen, U; Paulson, OB; Poulsen, HS; Sørensen, PS; Wagner, A | 1 |
| Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Kamdar, N; Pope, W; Satyamurthy, N; Schiepers, C; Silverman, DH | 1 |
| Barnett, CM; Brock, C; Bydder, GM; Charnley, N; Glaser, M; Matthews, J; Newlands, ES; Price, P; Swindell, R; West, CM | 1 |
| Berthelot, C; Blaire, T; Bouchet, F; Cahouet, A; Foussard, C; Giraud, S; Jeanguillaume, C; Lacoeuille, F; Lejeune, JJ; Metrard, G; Morel, O; Rakotonirina, H; Truchan-Graczyk, M | 1 |
| Iwamoto, S; Kamisaki, Y; Kawabe, H; Kawano, M; Noguchi, K; Seto, H; Shimizu, M; Takada, M; Watanabe, N | 1 |
| Kawai, N; Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Yamamoto, Y | 1 |
| Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E | 1 |
| Goto, M; Higashi, T; Mizumatsu, S; Nishimura, T; Sakai, K; Sugatani, H | 1 |
| Harpole, DH; McCall, LM; Posther, KE; Putnam, JB; Reed, CE; Rusch, VW; Siegel, BA | 1 |
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitzki, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Price, P | 1 |
| Weian, C; Xiangsong, Z | 1 |
| Macapinlac, HA | 1 |
| Clark, PB; Kraas, J; Morton, KA; Stubbs, E | 1 |
| Acerbi, F; Brotchi, J; Goldman, S; Levivier, M; Lubansu, A; Pirotte, B | 1 |
| Haba, R; Kawai, N; Kushida, Y; Miyake, K; Nagao, S; Nishiyama, Y; Sasakawa, Y; Tamiya, T; Yamamoto, Y | 1 |
| Coenen, HH; Floeth, FW; Jansen, P; Langen, KJ; Pauleit, D; Reifenberger, G; Riemenschneider, MJ; Sabel, M; Steiger, HJ; Stoffels, G | 1 |
| Karantanis, D; Mullan, BP; O'Neill, BP; Peller, PJ; Subramaniam, RM; Wiseman, GA; Witte, RJ | 1 |
| Hatazawa, J; Hori, M; Kajimoto, K; Kanai, Y; Kato, H; Kimura, Y; Kitagawa, K; Maruno, M; Oku, N; Tanaka, MR; Yoshimine, T | 1 |
| Hartmann, C; Plotkin, M; Stockhammer, F; Thomale, UW; Von Deimling, A | 1 |
| Asenbaum, S; Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Marosi, C; Pötzi, C; Szabo, M | 1 |
| Coel, MN; Jiang, CS; Ko, JP; Kwee, SA; Watters, MR | 1 |
| Niederkohr, RD; Quon, A; Rosenberg, J; Shabo, G | 1 |
| Wu, YG | 1 |
| Chen, W | 1 |
| Fortin, D; Larouche, A; Lecomte, R; Mathieu, D; Tsanaclis, AM | 1 |
| Kreth, FW; Pöpperl, G; Tatsch, K; Tonn, JC | 1 |
| Cross, JH; Harvey, AS; Mathern, BW; Mathern, GW; Shinnar, S | 1 |
| Chernov, MF; Hayashi, M; Hori, T; Izawa, M; Kubo, O; Muragaki, Y; Ono, Y; Takakura, K; Usukura, M; Yoshida, S | 1 |
| Bom, HS; Chung, TW; Kim, IY; Min, JJ; Seo, YS | 1 |
| Gómez-Río, M; Llamas-Elvira, JM; López-Ramírez, E; Ramos-Font, C; Rodríguez-Fernández, A | 1 |
| Atkinson, M; Fuerst, D; Guo, X; Johnson, R; Juhász, C; Kupsky, W; Shah, J; Watson, C | 1 |
| Fujibayashi, Y; Okazawa, H; Takeuchi, H; Tsuchida, T; Tsujikawa, T | 1 |
| Guan, Y; Huang, Z; Lin, X; Liu, P; Xue, F; Zhang, Z; Zuo, C | 1 |
| Amthauer, H; Plotkin, M; Stockhammer, F; van Landeghem, FK; Woiciechowsky, C | 1 |
| Liu, Y | 1 |
| Iwama, T; Kato, T; Maruyama, T; Miwa, K; Muragaki, Y; Nakayama, N; Okumura, A; Shinoda, J; Yano, H; Yoshimura, S | 1 |
| Boyett, JM; Fahey, FH; Kocak, M; Kun, LE; Pollack, IF; Poussaint, TY; Treves, ST; Williams, G | 1 |
| Aliaga, A; Assadian, S; Bedell, BJ; Del Maestro, RF; Evans, AC | 1 |
| Alexiou, GA; Fotopoulos, AD; Kyritsis, AP; Polyzoidis, KS; Tsiouris, S | 1 |
| Itoh, H; Kimura, H; Kosaka, N; Okazawa, H; Tsuchida, T; Uematsu, H | 1 |
| El-Haddad, G; Lilien, DL; Patterson, JC; Takalkar, AM | 1 |
| Carrasquillo, JA; Larson, SM | 1 |
| Mazziotta, JC; Phelps, ME; Schelbert, HR | 1 |
| Frackowiak, RS; Gibbs, JM; Hatazawa, J; Jones, T; Palmer, AJ; Rhodes, CG; Thomas, DG; Wise, RJ | 1 |
| Brooks, R; De La Paz, R; Di Chiro, G; Jabbari, B; Newmark, ME; Patronas, N; Sato, S; Theodore, WH | 1 |
| Brooks, RA; Channing, M; DeLaPaz, RL; Di Chiro, G; Kessler, RM; Kornblith, PL; Manning, RG; O'Connor, CM; Patronas, NJ; Rizzoli, HV; Smith, BH; Wolf, AP | 1 |
| Brooks, RA; DeLaPaz, RL; Di Chiro, G; Johnston, GS; Kessler, RM; Kornblith, PL; Kufta, CV; Manning, RG; Patronas, NJ; Smith, BH; Sokoloff, L; Wolf, AP | 1 |
| Besser, M; Dexter, MA; Ell, J; Fulham, MJ; Parker, GD | 1 |
| Coleman, RE; Hoffman, JM | 1 |
| Hatazawa, J; Iida, H; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shioya, H; Uemura, K | 1 |
| Hatazawa, J; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Sasaki, J; Tomura, N; Uemura, K | 1 |
| Abdel-Dayem, H; Holman, BL | 1 |
| Arbit, E; Canete, A; Cheung, NK; Cordon-Cardo, C; Daghighian, F; Finn, R; Larson, SM; Pentlow, K; Yeh, SD; Zhang, JJ | 1 |
| Balériaux, D; Bidaut, LM; Brotchi, J; Brucher, JM; Goldman, S; Levivier, M; Luxen, A; Pirotte, B; Stanus, E | 1 |
| Thie, JA | 1 |
| Bol, AC; De Volder, AG; Duprez, TP; Evrard, P; Gadisseux, JF; Grandin, CB; Maloteaux, JM; Michel, CJ | 1 |
| Roelcke, U | 1 |
| Blasberg, RG | 1 |
| Alavi, A; Alavi, JB; Buchpiguel, CA; Kenyon, LC | 1 |
| Bicik, I; Di Chiro, G; Fulham, MJ; Knightly, JJ; Raman, R | 1 |
| Balériaux, D; Brotchi, J; Brucher, JM; Goldman, S; Hildebrand, J; Levivier, M; Luxen, A; Pirotte, B | 1 |
| Conti, PS | 1 |
| Delbeke, D; Jennings, MT; Kessler, RM; Lapidus, RL; Maciunas, RJ; Meyerowitz, C; Moots, PL | 1 |
| Aoki, S; Fujii, H; Kosuda, S; Nakamura, O; Shitara, N; Suzuki, K; Tanaka, Y | 1 |
| Böcking, A; Cremerius, U; Gilsbach, J; Henn, W; Lippitz, B; Mull, M; Schröder, JM; Striepecke, E; Weis, J; Zang, KD | 1 |
| Bushnell, DL; Follett, KA; Kahn, D; Kirchner, PT; Madsen, M; Nathan, MA; Piper, JG | 1 |
| Ishikawa, M; Ishizu, K; Magata, Y; Miyatake, S; Nishizawa, S; Okazawa, H; Sadato, N; Tamaki, N; Tsuchida, T; Yonekura, Y | 1 |
| Fazio, F; Grana, C; Lucignani, G; Messa, C | 1 |
| Anderson, JH; Barker, PB; Blackband, SJ; Conti, PS; Dannals, RF; Hilton, J; Natarajan, TK; Samphilipo, MA; Strandberg, JD; Wong, DF | 1 |
| Hatazawa, J; Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Uemura, K | 1 |
| Beam, C; Coleman, RE; Crain, BJ; Friedman, AH; Hanson, MW; Hoffman, JM; Lewis, DV; Radtke, RA; Walczak, TS | 1 |
| Arroyo, S; Lesser, RP | 1 |
| Berthold, F; Heiss, WD; Herholz, K; Holthoff, VA; Neubauer, I; Schröder, R; Widemann, B | 1 |
| Glaspy, JA; Hawkins, R; Hoh, CK; Phelps, ME | 1 |
| Ishikawa, M; Kikuchi, H; Miyatake, S; Nishizawa, S; Oda, Y; Yonekura, Y | 1 |
| Di Chiro, G; Dwyer, AJ; Fulham, MJ; Melisi, JW; Nishimiya, J | 1 |
| Cohen, JD; Hanson, JM; Levine, RL; Mehta, MP; Nickles, RJ; Rozental, JM | 1 |
| Aberle, DR; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Phelps, ME; Razavi, MK; Rege, SD | 1 |
| Dehdashti, F; Fusselman, MJ; Griffeth, LK; McGuire, AH; Rich, KM; Siegel, BA; Simpson, JR | 1 |
| Antonini, A; Hajek, M; Leenders, KL; Wieser, HG | 1 |
| Brotchi, J; Goldman, S; Levivier, M; Pirotte, B | 1 |
| Coleman, RE; Gray, L; Hanson, MW; Hoffman, JM; Rosenfeld, S; Schifter, T; Waskin, HA | 1 |
| Bruner, JM; Janus, TJ; Kim, EE; Tilbury, R; Yung, WK | 1 |
| Hausmann, O; Leenders, KL; Maguire, RP; Radü, EW; Roelcke, U; von Ammon, K | 1 |
| Larcos, G; Maisey, MN | 1 |
| Hatazawa, J; Iwase, M; Kado, H; Kanno, I; Ogawa, T; Okudera, T; Uemura, K | 1 |
| Ahmad, K; Endo, K; Hirano, T; Horikoshi, S; Inoue, T; Oriuchi, N; Sarwar, M; Shibasaki, T; Suzuki, H; Tamura, M; Tokunaga, M; Tomiyoshi, K; Watanabe, N | 1 |
| Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC | 1 |
| Brotchi, J; Damhaut, P; De Witte, O; Goldman, S; Hildebrand, J; Levivier, M; Salmon, I; Violon, P; Wikler, D | 1 |
| Deshmukh, A; Fischman, AJ; Gruber, M; Hochberg, FH; Palmer, EL; Scott, JA | 1 |
| Hatazawa, J; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Uemura, K; Yasui, N | 1 |
| Fukui, M; Hisada, K; Ichiya, Y; Inoue, T; Kuwabara, Y; Masuda, K; Morioka, T; Sasaki, M; Yoshida, T | 1 |
| Heiss, WD; Herholz, K; Lanfermann, H; Pietrzyk, U; Thiel, A; Wagner, R; Wienhard, K | 1 |
| Barker, FG; Chang, SM; Pounds, TR; Prados, MD; Valk, PE | 1 |
| Dimitrakopoulou-Strauss, A; Doll, J; Gutzler, F; Irngartinger, G; Oberdorfer, F; Strauss, LG; Stremmel, W; van Kaick, G | 1 |
| Beaudouin, V; Chapon, F; Courtheoux, P; Creveuil, C; Derlon, JM; Houtteville, JP; Noël, MH; Petit-Taboué, MC | 1 |
| Collins, VP; Ericson, K; Karlsson, B; Kihlström, L; Lindquist, C; Mogard, J; Stone-Elander, S; Widén, L | 1 |
| Brandau, W; Kuwert, T; Lerch, H; Matheja, P; Morgenroth, C; Palkovic, S; Samnick, S; Schäfers, K; Schäfers, M; Schober, O; Vollet, B; Wassmann, H; Woesler, B | 1 |
| Burkhard, P; Delavelle, J; Maton, B; Morel, C; Otten, P; Papazyan, JP; Pizzolato, GP; Rossier, P; Rüfenacht, DA; Slosman, DO | 1 |
| Bartenstein, P; Daschner, H; Feldmann, HJ; Gross, MW; Kinzel, D; Lumenta, C; Molls, M; Reidel, G; Schwaiger, M; Weber, W; Ziegler, SI | 1 |
| Alpert, NM; Fischman, AJ; Frosch, MP; Gonzalez, RG; Swearinger, B; Thornton, AF | 1 |
| Brotchi, J; Damhaut, P; David, P; Goldman, S; Levivier, M; Pirotte, B; Salmon, L; Vandesteene, A; Wikler, D | 1 |
| Brotchi, J; Brucher, JM; Damhaut, P; Dethy, S; Goldman, S; Hildebrand, J; Levivier, M; Pirotte, B; Wikler, D | 1 |
| Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G | 1 |
| Brotchi, J; Damhaut, P; De Witte, O; Goldman, S; Hildebrand, J; Levivier, M; Monclus, M; Pirotte, B; Wikler, D | 1 |
| Lapela, M; Leskinen, S; Lindholm, P; Minn, H | 1 |
| Barrington, SF; Bradbeer, CS; Campbell, M; Lowe, J; O'Doherty, MJ | 1 |
| Beattie, B; Blasberg, R; Finn, R; Joshi, R; Miyagawa, T; Oku, T; Tjuvajev, J; Uehara, H | 1 |
| Gullotta, F; Kuwert, T; Probst-Cousin, S; Schäfers, M; Schober, O; Wassmann, H; Woesler, B | 1 |
| Carreras Delgado, JL | 1 |
| Montz, HR | 1 |
| Bandy, DJ; Chen, K; Duncan, JD; Kaplan, AM; Lawson, MA; Manwaring, K; Moss, SD; Reiman, EM; Wodrich, DL | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Tsuyuguchi, N | 1 |
| Bryan, RN | 1 |
| Hausmann, O; Leenders, KL; Maguire, RP; Missimer, J; Müller-Brand, J; Otte, A; Radü, EW; Roelcke, U; von Ammon, K | 1 |
| Degueldre, C; Del Fiore, G; Deprez, M; Kaschten, B; Luxen, A; Reznik, M; Sadzot, B; Stevenaert, A | 1 |
| Hirano, T; Horikoshi, S; Kurihara, H; Ono, N; Oriuchi, N; Shibasaki, T; Tamura, M; Zama, A | 1 |
| El-Saden, SM; Goy, BW; Kincaid, PK; Park, SH | 1 |
| Sfakianakis, G | 1 |
| Fukushi, K; Irie, T; Iwadate, Y; Iyo, M; Namba, H; Sakiyama, S; Sueyoshi, K; Tagawa, M | 1 |
| Akabani, G; Brown, MT; Coleman, RE; Hanson, MW; Marriott, CJ; McLendon, RE; Thorstad, W | 1 |
| Bauer, B; Heiss, WD; Herholz, K; Hölzer, T; Pietrzyk, U; Schröder, R; Sturm, V; Treuer, H; Voges, J; Würker, M | 1 |
| Cinotti, L; Fischer, G; Froment, JC; Gogoleva, SM; Jouvet, A; Mauguière, F; Ryvlin, P; Saint Pierre, G; Sindou, M; Veyre, L | 1 |
| Fukui, M; Fukumura, T; Kuwabara, Y; Masuda, K; Mihara, F; Morioka, T; Nakagawa, M; Sasaki, M; Yoshida, T | 1 |
| Blasberg, RG; Claffey, KP; Finn, R; Joshi, A; Joshi, R; Miyagawa, T; Oku, T; Sasajima, T; Tjuvajev, JG | 1 |
| Cho, BK; Chung, JK; Jung, HW; Kim, CY; Kim, DG; Lee, DS; Paek, SH | 1 |
| Drane, WE; Jimenez, LA; Maria, BL; Mastin, ST | 1 |
| Camp, VM; Eshima, D; Eshima, L; Goodman, MM; Hoffman, JM; Olson, J; Shoup, TM; Stabin, M; Votaw, D; Votaw, J | 1 |
| Al-Watban, J; Bakheet, SM; Hassounah, M; Homsi, M; Larsson, S; Powe, J | 1 |
| Amano, S; Aoki, J; Aoyagi, K; Endo, K; Ida, I; Inoue, T; Mikuni, M; Oriuchi, N; Shibasaki, T; Tomiyoshi, K | 1 |
| Dietlein, M; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Smolarz, K; Stützer, H | 1 |
| Amsler, B; Bruehlmeier, M; Gratzl, O; Hausmann, O; Landmann, C; Leenders, KL; Radü, EW; Roelcke, U; Schubert, KH; von Ammon, K | 1 |
| Delbeke, D | 1 |
| O'Sullivan, F; Saha, A | 1 |
| Hellwig, A; Hellwig, D; Kirsch, CM; Leutz, M; Palm, I; Rentz, K; Sybrecht, GW; Ukena, D | 1 |
| Buell, U; Gilsbach, J; Hermanns, B; Krombach, G; Meyer, P; Sabri, O; Schreckenberger, M; Schulz, G; Spetzger, U | 1 |
| Stevens, H; Stokkel, M; Taphoorn, M; Van Rijk, P | 1 |
| Fujibayashi, Y; Ishii, Y; Kubota, T; Maruyama, I; Sadato, N; Tsuchida, T; Waki, A; Yonekura, Y; Yoshida, M | 1 |
| Dillon, WP; Nelson, SJ; Vigneron, DB | 1 |
| Hatazawa, J; Kowada, M; Mineura, K; Ogawa, T; Shioya, H; Uemura, K | 1 |
| Bloomfield, SM; Gupta, NC; Nicholson, P | 1 |
| Coleman, RE; Culhane, DK; Erasmus, JJ; Goodman, PC; Herndon, JE; Marom, EM; McAdams, HP; Patz, EF | 1 |
| Bandy, DJ; Bonstelle, CT; Kaplan, AM; Lawson, MA; Manwaring, KH; Moss, SD; Reiman, EM; Spataro, J | 1 |
| Bandy, DJ; Chen, K; Duncan, JD; Kaplan, AM; Lawson, MA; Manwaring, KH; Moss, SD; Reiman, EM; Schnur, JA; Wodrich, DL | 1 |
| Alavi, A; Benard, F; Bhatnagar, A; Hustinx, R; Smith, RJ | 1 |
| Arata, MA; Coleman, RE; McLendon, RE; Provenzale, JM; Turkington, TG | 1 |
| Otte, A | 1 |
| Aärimaa, T; Harila-Saari, A; Kähkönen, M; Korhonen, T; Metsähonkala, L; Minn, H; Norvasuo-Heilä, MK; Ruotsalainen, U; Salmi, TT; Solin, O; Suhonen-Polvi, H; Utriainen, T | 1 |
| Beattie, B; Blasberg, RG; Crompton, NE; Finn, RD; Guenther, I; Knust, EJ; Koziorowski, J; Landolt, H; Leenders, KL; Maguire, RP; Missimer, J; Roelcke, U; von Ammon, K; Vontobel, P; Weinreich, R; Yonekawa, Y | 1 |
| Brock, CS; Evans, H; Matthews, J; Newlands, ES; O'Reilly, SM; Osman, S; Price, PM; Young, H | 1 |
| Büll, U; Meyer, PT; Sabri, O; Schreckenberger, M; Setani, K; Zeggel, T | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU | 1 |
| Choi, JY; Kim, BT; Kim, JH; Kim, SE; Shin, HJ | 1 |
| Boerner, AR; Schicha, H; Theissen, P; Voth, E; Wagner, R; Wienhard, K | 1 |
| Delbeke, D; Patton, JA; Sandler, MP | 1 |
| Go, KG; Haaxma-Reiche, H; Pruim, J; Que, TH; Vaalburg, W | 1 |
| Fernandez, O; Galbis, J; Garcia-Velloso, MJ; Richter, J; Torre, W | 1 |
| Fujii, R; Horii, H; Ido, T; Imahori, Y; Kanatsuna, T; Mineura, K; Nakajima, S; Nakamura, T; Shimizu, M; Wakita, K | 1 |
| Maisey, MN; Plowman, PN; Saunders, CA | 1 |
| Haque, M; Matsuoka, Y; Matsusaka, Y; Sunada, I; Tsuyuguchi, N | 1 |
| Brotchi, J; De Witte, O; Goldman, S; Lefranc, F; Levivier, M; Salmon, I | 1 |
| Burrows, RC; Freeman, SD; Graham, MM; Krohn, KA; Link, JM; Muzi, M; Spence, AM; Wiseman, RW | 1 |
| Buell, U; Meyer, GF; Meyer, PT; Sabri, O; Schreckenberger, M; Setani, KS; Spetzger, U; Zeggel, T | 1 |
| Kurlemann, G; Löttgen, J; Matheja, P; Palkovic, S; Paulus, W; Rickert, CH; Schober, O; Sträter, R; Wassmann, H; Weckesser, M | 1 |
| Kawai, K; Kirino, T; Kurita, H; Momose, T; Shin, M; Suzuki, I; Tago, M | 1 |
| Barnett, G; Chao, ST; Lee, SY; Raja, S; Suh, JH | 1 |
| Knoll, P; Kohn, H; Mirzaei, S | 1 |
| Enomoto, S; Oku, N; Takeda, A; Tamano, H | 1 |
| Fujibayashi, Y; Itoh, H; Kubota, T; Maruyama, I; Nishizawa, S; Tsuchida, T; Waki, A; Yamamoto, T; Yonekura, Y; Yoshida, M | 1 |
| Bohuslavizki, KH; Buchert, R; Clausen, M; Jenicke, L; Obrocki, J; Petersen, K; Thomasius, R; Väterlein, O | 1 |
| Boers, M; Devillé, W; Hoekstra, OS; Hooft, L; Lips, P; Teule, GJ; van Tulder, MW | 1 |
| Alberini, JL; Belhocine, T; Bolle, S; Daenen, F; Rigo, P; Rutten, I | 1 |
| Jeong, JH; Kim, GM; Na, DL; Yoon, SJ | 1 |
| Higashiyama, S; Inoue, Y; Kawabe, J; Koyama, K; Ochi, H; Ohachi, Y; Okamura, T; Sakamoto, H; Shakudo, M; Yamada, R | 1 |
| Buell, U; Gilsbach, J; Meyer, PT; Sabri, O; Schreckenberger, M; Spetzger, U; Zeggel, T; Zimny, M | 1 |
| Coleman, RE; Hagge, RJ; Wong, TZ | 1 |
| Derlon, JM | 1 |
| Inoue, T; Ishiuchi, S; Kurihara, H; Ohtani, T; Oriuchi, N; Saito, N; Sasaki, T | 1 |
| Buell, U; Foltys, H; Gilsbach, JM; Kemeny, S; Korinth, M; Krings, T; Meyer, PT; Möller-Hartmann, W; Reinges, MH; Rohde, V; Sabri, O; Schreckenberger, M; Spetzger, U; Thron, A | 1 |
| Alavi, A; Reivich, M | 1 |
| Elsinga, PH; Groen, HJ; Pieterman, RM; Pruim, J; Que, TH; Vaalburg, W; van Putten, JW; Willemsen, AT | 1 |
| Bader, JB; Feiden, W; Hellwig, D; Kirsch, CM; Moringlane, JR; Romeike, BF; Samnick, S | 1 |
| Eichhorn, K; Freitag, P; Gratzl, O; Hofer, S; Maecke, R; Merlo, A; Mueller-Brand, J; Probst, A; Reubi, JC; Schumacher, T; Wasner, M; Zimmerer, S | 1 |
| Chung, JK; Jeong, JM; Jung, HW; Kim, SK; Kim, YK; Lee, DS; Lee, MC; Lee, YJ; Paek, S; Yeo, JS | 1 |
| Balkay, L; Csécsei, G; Emri, M; Esik, O; Galuska, L; Molnár, P; Novák, L; Trón, L | 1 |
| Meyer, GJ; Schober, O | 1 |
| Balériaux, D; Bidaut, LM; Brotchi, J; Goldman, S; Hildebrand, J; Levivier, M; Luxen, A; Przedborski, S; Stanus, E | 1 |
| Kessler, RM; Maciunas, RJ; Mandava, V; Maurer, C; Smith, G; Watt, G | 1 |
| Erlandsson, K; Hellborg, R; Ohlsson, T; Sandell, A; Strand, SE | 1 |
| Alagona, P; Cacciatore, R; Eikman, EA; Zangara, L | 1 |
| Heiss, WD; Herholz, K; Rudolf, J | 1 |
| Cho, BJ; Chung, SK; Haynie, TP; Kim, CG; Kim, EE; Moser, RP; Podoloff, DA; Tilbury, RS; Yang, DJ; Yung, WK | 1 |
| denHollander, JA; Friedmann, G; Heindel, W; Heiss, WD; Herholz, K; Kugel, H; Luyten, PR; Pietrzyk, U; Voges, J | 1 |
| Ishikawa, M; Iwasaki, Y; Kikuchi, H; Mukai, T; Nagata, I; Nishizawa, S; Taki, W; Yamagata, S; Yonekura, Y | 1 |
| Coenen, HH; Heiss, WD; Herholz, K; Kling, P; Rudolf, J; Stöcklin, G; Wienhard, K | 1 |
| Burger, PC; Coleman, RE; Friedman, AH; Glantz, MJ; Hanson, MW; Herndon, JE; Hoffman, JM; Meisler, WJ; Schold, SC | 1 |
| Rozental, JM | 1 |
| Coleman, RE; Hanson, MW; Hoffman, JM; Schold, SC; Sostman, HD | 1 |
| Conti, PS; Strauss, LG | 1 |
| Fink, G; Hamacher, K; Heiss, WD; Nebeling, B; Pawlik, G; Rudolf, J; Stöcklin, G; Wienhard, K | 1 |
| Algan, O; Hanson, JM; Kinsella, TJ; Levin, AB; Levine, RL; Mehta, MP; Mendoza, M; Nickles, RJ; Rozental, JM; Schrader, DA | 1 |
| Alavi, A; Alavi, JB; Kim, CK; Reivich, M | 1 |
| Levine, RL; Nickles, RJ; Rozental, JM | 1 |
| Maker, HS | 1 |
| Fujita, H; Higano, S; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Shishido, F; Uemura, K; Yasui, N | 1 |
| Darling, JL; Gill, SS; Parkins, CS; Thomas, DG; Wilson, CB | 1 |
| Alavi, A; Alavi, JB; Lenkinski, RE | 1 |
| Alger, JR; Bizzi, A; Black, JL; DeSouza, BX; Duhaney, MO; Frank, JA; Fulham, MJ; Inscoe, SW; Moonen, CT; van Zijl, PC | 1 |
| Bunke, J; Friedmann, G; Heindel, W; Heiss, WD; Herholz, K; Jeske, J; Rudolf, J | 1 |
| Dobkin, JA; Hanson, JM; Levine, RL; Nickles, RJ; Rozental, JM | 1 |
| Budinger, TF; Derenzo, SE; Geyer, AB; Huesman, RH; Jagust, WJ; Valk, PE | 1 |
| Kirikae, M | 1 |
| Kowada, M; Mineura, K; Ogawa, T; Sasajima, T; Shishido, F; Suda, Y; Uemura, K | 1 |
| Wilson, CB | 1 |
| Dobkin, JA; Levine, RL; Nickles, RJ; Rozental, JM | 1 |
| Heindel, W; Heiss, WD; Herholz, K; Jeske, J | 1 |
| Hino, A; Hirakawa, K; Imahori, Y; Mizukawa, N; Nakahashi, H; Oki, F; Tenjin, H; Yamashita, M; Yano, I; Yoshino, E | 1 |
| Alavi, A; Alavi, JB; Dann, R; Goldberg, HI; Hickey, W; Reivich, M | 1 |
| Budinger, TF; Doyle, WK; Gutin, PH; Levin, VA; Silver, P; Valk, PE | 1 |
| Mazziotta, JC; Phelps, ME | 1 |
| Alavi, A; Alavi, J; Chawluk, J; Dann, R; Kushner, M; Reivich, M | 1 |
| Higano, S; Inugami, A; Kanno, I; Mineura, K; Murakami, M; Ogawa, T; Sasaki, H; Shishido, F; Uemura, K; Yamaguchi, T | 2 |
| Bairamian, D; Di Chiro, G; Kornblith, PL; Kufta, C; Larson, SM; Patronas, NJ; Simon, R | 1 |
| Kowada, M; Mineura, K; Ogawa, T; Shishido, F; Uemura, K; Yasuda, T | 1 |
| Dohrmann, GJ; Lichtor, T | 1 |
| Kwee, IL; Nakada, T | 1 |
| De Michele, D; Di Chiro, G; Doppman, JL; Ito, M; Katz, DA; Kufta, CV; Larson, SM; Oldfield, E; Patronas, NJ; Wright, DC | 1 |
| Alavi, A; Alavi, JB; Chawluk, J; Hickey, W; Kushner, M; Powe, J; Reivich, M | 1 |
| Brooks, RA; Di Chiro, G | 1 |
| Heiss, WD; Herholz, K; Pawlik, G; Staffen, W; Wagner, R; Wienhard, K; Ziffling, P | 1 |
| Hawkins, RA; Huang, SC; Phelps, ME | 1 |
| Di Chiro, G | 2 |
| Blacklock, JB; Di Chiro, G; Larson, SM; Oldfield, EH; Theodore, W; Tran, D; Wright, DC | 1 |
| Beil, C | 1 |
| Alavi, A; Alavi, J; Chawluk, J; Fazekas, F; Kushner, M; Reivich, M; Rosen, M; Tobin, M | 1 |
| Miraldi, F | 1 |
| Kanno, I; Miura, S; Murakami, M; Sasaki, H; Shishido, F; Takahashi, K; Uemura, K | 1 |
| Diksic, M; Feindel, W; Kato, A; Sako, K; Yamamoto, YL | 1 |
102 review(s) available for fluorodeoxyglucose f18 and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
Topics: Adult; Amino Acids; Brain Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Neurosurgeons; Positron-Emission Tomography; Practice Guidelines as Topic | 2022 |
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Facts and Fictions About [
Topics: Amino Acids; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography | 2022 |
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.
Topics: Amino Acids; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
PET/CT imaging of giant primary pulmonary meningioma: a case report and literature review.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
The diagnostic performance of 18 fluorine-fluorodeoxyglucose PET for brain metastases: a systematic review and meta-analysis.
Topics: Brain; Brain Neoplasms; Fluorine; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
Solitary vertebral metastatic glioblastoma in the absence of primary brain tumor relapse: a case report and literature review.
Topics: Adult; Brain Neoplasms; Cervical Vertebrae; Fatal Outcome; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Treatment Outcome | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Imaging Glioblastoma Posttreatment: Progression, Pseudoprogression, Pseudoresponse, Radiation Necrosis.
Topics: Brain; Brain Neoplasms; Contrast Media; Diagnostic Imaging; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Necrosis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Treatment Outcome | 2021 |
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.
Topics: Artificial Intelligence; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors.
Topics: Brain Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Comparison of Gadolinium-enhanced MRI and 18FDG PET/PET-CT for the diagnosis of brain metastases in lung cancer patients: A meta-analysis of 5 prospective studies.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Gadolinium; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2018 |
State of the Art Treatment and Surveillance Imaging of Glioblastomas.
Topics: Angiogenesis Inhibitors; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunotherapy; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Research Design | 2018 |
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.
Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Neoplasm Grading; Positron-Emission Tomography; Tyrosine | 2019 |
PET in the clinical management of glioma: evidence map.
Topics: Biopsy; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Rosai-Dorfman disease with extranodal involvement.
Topics: Biopsy, Needle; Brain Neoplasms; Craniotomy; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Histiocytosis, Sinus; Humans; Immunohistochemistry; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Neck Pain; Photomicrography; Positron-Emission Tomography; Prednisolone; Rare Diseases; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography | 2013 |
A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors.
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Methionine; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2014 |
[Possibilities of using molecular imaging methods with complex modern radiopharmaceuticals in neurooncology].
Topics: Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2015 |
[PET in gliomas. Overview of current studies].
Topics: Brain Neoplasms; Evidence-Based Medicine; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Postradiation changes in tissues: evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings.
Topics: Bone and Bones; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Lung; Magnetic Resonance Imaging; Multimodal Imaging; Necrosis; Neoplasms; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Spinal Cord; Tissue Distribution; Tomography, X-Ray Computed; Urinary Tract | 2014 |
Clinical applications of choline PET/CT in brain tumors.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Glioma; Half-Life; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
PET imaging for brain tumor diagnostics.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2014 |
¹⁸F-fluorodeoxyglucose PET/computed tomography for primary brain tumors.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Positron emission tomography-magnetic resonance imaging in the evaluation of brain tumors: current status and future prospects.
Topics: Brain; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Forecasting; Humans; Image Enhancement; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
Topics: Adolescent; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Neuroblastoma; Pediatrics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Wilms Tumor | 2015 |
Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PET.
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Meningeal Carcinomatosis; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Brain metastases of parathyroid carcinoma: Review of the literature and a case report.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Parathyroid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2015 |
(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
Topics: Brain Neoplasms; Early Detection of Cancer; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Advances in diagnosis and treatment of metastatic cervical cancer.
Topics: Bone Neoplasms; Brain Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
Molecular imaging of brain tumors with radiolabeled choline PET.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Brain Tumors: An Update on Clinical PET Research in Gliomas.
Topics: Biomarkers, Tumor; Brain Neoplasms; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography | 2017 |
PET imaging of brain tumors.
Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
Treatment algorithms in refractory partial epilepsy.
Topics: Algorithms; Anticonvulsants; Brain Neoplasms; Decision Trees; Electroencephalography; Epilepsies, Partial; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neocortex; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Videotape Recording | 2009 |
Noninvasive assessment of pediatric brain tumors.
Topics: Brain Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature.
Topics: Aged; Brain Neoplasms; Coronary Angiography; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography | 2010 |
PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.
Topics: Animals; Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radioactive Tracers | 2010 |
The pre-requisite of a second-generation glioma PET biomarker.
Topics: Biomarkers; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
The use of FDG-PET to target tumors by radiotherapy.
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
FDG-PET/CT in pediatric solid tumors.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Fluorodeoxyglucose F18; Hepatoblastoma; Histiocytosis, Langerhans-Cell; Humans; Liver Neoplasms; Neoplasms; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
Assessing extracranial tumors using diffusion-weighted whole-body MRI.
Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Ganglioglioma; Humans; Infant; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
PET and SPECT in brain tumors and epilepsy.
Topics: Brain; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Epilepsy; Flumazenil; Fluorodeoxyglucose F18; GABA Modulators; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2011 |
Multimodality assessment of brain tumors and tumor recurrence.
Topics: Amino Acids; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Education, Medical, Continuing; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Hypoxia, Brain; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, X-Ray Computed | 2011 |
18F-FDG-PET/CT.
Topics: Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
Measurement of glucose consumption using [(18)F]fluorodeoxyglucose.
Topics: Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Models, Biological; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[A proposal for the rational use of the PET in oncology].
Topics: Brain Neoplasms; Colorectal Neoplasms; Consensus; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Spain; Tomography, Emission-Computed | 2002 |
[Clinical impact of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of brain diseases].
Topics: Brain; Brain Diseases; Brain Neoplasms; Fluorodeoxyglucose F18; HIV Infections; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography imaging of brain tumors.
Topics: Blood Volume; Brain Neoplasms; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Assessment of therapy response by FDG PET in pediatric patients.
Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Lymphoma; Male; Neoplasms; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
Topics: Brain; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Glioma; Methionine; Methyltyrosines; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
[Positron emission tomography in oncology].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Molecular imaging of gliomas.
Topics: Animals; Brain Neoplasms; Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Expression Profiling; Genetic Markers; Genetic Therapy; Genetic Vectors; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Molecular Biology; Radiopharmaceuticals; Signal Transduction; Tomography, Emission-Computed | 2002 |
[Functional imaging in brain tumors].
Topics: Adenoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Meningioma; Neurilemmoma; Oligodendroglioma; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Role of surgery in patients with stage IV melanoma.
Topics: Brain Neoplasms; Decision Making; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Melanoma; Neoplasm Staging; Palliative Care; Radiography; Radiopharmaceuticals; Risk Factors; Tomography, Emission-Computed | 2004 |
2-deoxy-fluorglucose-positron emission tomography imaging of the brain: current clinical applications with emphasis on the dementias.
Topics: Brain; Brain Mapping; Brain Neoplasms; Cerebrovascular Disorders; Craniocerebral Trauma; Dementia; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals | 2004 |
PET imaging for differentiating recurrent brain tumor from radiation necrosis.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiopharmaceuticals | 2005 |
[Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
Topics: Brain Neoplasms; Diagnostic Imaging; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
[Usefulness of FDG-PET for the diagnosis of brain tumors].
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2005 |
PET/CT in oncology: a major technology for cancer care.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasms; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2005 |
[Clinical application of positron emission tomography and 18FDG to brain tumor].
Topics: Aged; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy | 2005 |
True tracers: comparing FDG with glucose and FLT with thymidine.
Topics: Animals; Brain; Brain Mapping; Brain Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Thymidine | 2005 |
[PET and malignant cerebral tumors].
Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
The role of PET scanning in determining pharmacoselective doses in oncology drug development.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Design; Fluorodeoxyglucose F18; Humans; Models, Chemical; Neoplasms; Perfusion; Positron-Emission Tomography; Technology, Pharmaceutical; Time Factors | 2007 |
Positron emission tomography of the brain.
Topics: Brain; Brain Diseases; Brain Neoplasms; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findings.
Topics: Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders].
Topics: Adult; Brain; Brain Neoplasms; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Nervous System Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Synaptic Transmission | 2007 |
Clinical applications of PET in brain tumors.
Topics: Adult; Amino Acids; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Brain tumors.
Topics: Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Nuclear oncology 1984.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bleomycin; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Liver Neoplasms; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins; Neoplasms; Tomography, Emission-Computed | 1984 |
Positron computed tomography for studies of myocardial and cerebral function.
Topics: Alzheimer Disease; Animals; Brain; Brain Neoplasms; Cardiomyopathies; Cerebrovascular Disorders; Deoxyglucose; Dogs; Epilepsy; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Huntington Disease; Regional Blood Flow; Tomography, Emission-Computed | 1983 |
The clinical role of SPECT in patients with brain tumors.
Topics: Amphetamines; Animals; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iofetamine; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
PET: brain tumor biochemistry.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Blood-Brain Barrier; Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Polyamines; Receptors, GABA-A; Tomography, Emission-Computed | 1994 |
Prediction of brain tumor therapy response by PET.
Topics: Amino Acids; Blood-Brain Barrier; Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Oxygen Consumption; Predictive Value of Tests; Prognosis; Tomography, Emission-Computed | 1994 |
Introduction to imaging brain tumor metabolism with positron emission tomography (PET).
Topics: Brain; Brain Diseases; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1995 |
Functional imaging using PET and SPECT in pediatric neurology.
Topics: Brain Diseases; Brain Neoplasms; Child; Deoxyglucose; Epilepsy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Use of positron emission tomography in oncology.
Topics: Brain Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1993 |
Positron emission tomography and brain tumours.
Topics: Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Prognosis; Tomography, Emission-Computed; Treatment Outcome | 1997 |
Metabolic imaging by positron emission tomography in oncology.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasms; Radiography; Tomography, Emission-Computed | 1997 |
Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.
Topics: Artifacts; Brain Neoplasms; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.
Topics: Animals; Astrocytoma; Blood Volume; Brachytherapy; Brain; Brain Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Radiography; Radiosurgery; Tomography, Emission-Computed | 1999 |
[Diagnostic value of positron emission tomography (PET) in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Urogenital Neoplasms | 2000 |
Positron emission tomography: brain tumors and lung cancer.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Evaluation of brain tumors using positron emission tomography].
Topics: Astrocytoma; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioblastoma; Humans; Tomography, Emission-Computed | 1992 |
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
Topics: Blood Glucose; Brain Neoplasms; Child; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Glioma; Humans; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
Assessment: positron emission tomography. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Topics: Brain Neoplasms; Cognition Disorders; Dementia; Deoxyglucose; Diagnosis, Differential; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Oxygen Radioisotopes; Preoperative Care; Seizures; Tomography, Emission-Computed | 1991 |
Clinical application of PET for the evaluation of brain tumors.
Topics: Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1991 |
The applications of PET in clinical oncology.
Topics: Brain Neoplasms; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasms; Tomography, Emission-Computed | 1991 |
Metabolic imaging of human brain tumors.
Topics: Brain Neoplasms; Deoxyglucose; Floxuridine; Fluorodeoxyglucose F18; Glucose; Humans; Nerve Tissue Proteins; Nucleic Acids; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Positron emission tomography: human brain function and biochemistry.
Topics: Acoustic Stimulation; Bipolar Disorder; Brain; Brain Diseases; Brain Neoplasms; Cerebrovascular Circulation; Cerebrovascular Disorders; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Kinetics; Mental Disorders; Neurotransmitter Agents; Oxygen Consumption; Pharmaceutical Preparations; Pharmacology; Photic Stimulation; Tomography, Emission-Computed; Visual Cortex | 1985 |
Positron emission tomography imaging of regional cerebral glucose metabolism.
Topics: Aging; Brain; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Dementia; Deoxyglucose; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Parkinson Disease; Radiography; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed | 1986 |
Potential of NMR and PET for determining tumor metabolism.
Topics: Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Neoplasms; Oxygen Consumption; Tomography, Emission-Computed | 1986 |
45 trial(s) available for fluorodeoxyglucose f18 and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.
Topics: Brain Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2018 |
Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Topics: Adult; Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Middle Aged; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Pressure | 2014 |
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Axitinib; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Imidazoles; Indazoles; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Radiopharmaceuticals; Steroids; Treatment Outcome; Young Adult | 2016 |
Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A | 2016 |
ANG1005 for breast cancer brain metastases: correlation between
Topics: Adult; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Peptides; Positron-Emission Tomography; Treatment Outcome | 2016 |
Effect of cervical spinal cord stimulation on cerebral glucose metabolism.
Topics: Adult; Blood Glucose; Brain Neoplasms; Electric Stimulation Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Spinal Cord | 2008 |
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Topics: Adolescent; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tyrosine; Young Adult | 2009 |
Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
Topics: Adult; Aged; Astrocytoma; Biopsy; Brain Neoplasms; Carbon Isotopes; Cell Division; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia, Brain; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Nitroimidazoles; Oligodendroglioma; Positron-Emission Tomography; Protons; Radiopharmaceuticals | 2010 |
Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Mapping; Brain Neoplasms; Carmustine; Cerebrovascular Circulation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Injections, Intramuscular; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Thallium; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Everolimus; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sirolimus; Temozolomide | 2011 |
Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
Topics: Adult; Aged; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Prognosis; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnosis, Differential; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms | 2004 |
Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.
Topics: Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioma; Glucose Transporter Type 1; Humans; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stereotaxic Techniques; Surgery, Computer-Assisted; Tomography, Emission-Computed | 2004 |
High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications.
Topics: Adult; Amino Acids; Brain; Brain Neoplasms; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Oligodendroglioma; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Male; Middle Aged; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2004 |
A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.
Topics: Brain Neoplasms; Feasibility Studies; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2004 |
Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sample.
Topics: Arteries; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regional Blood Flow; Sensitivity and Specificity | 2005 |
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.
Topics: Brain Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2006 |
PET imaging of brain astrocytoma with 1-11C-acetate.
Topics: Acetates; Adult; Astrocytoma; Brain Neoplasms; Carbon; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Evaluation of tumor FDG transport and metabolism in primary central nervous system lymphoma using [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) kinetic analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Transport, Active; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma; Male; Metabolic Clearance Rate; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Vincristine | 2005 |
Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neuronavigation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
A prospective PET study of patients with glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Middle Aged; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy; Sample Size; Treatment Outcome | 2006 |
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Topics: Adult; Aged; Brain Neoplasms; California; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme.
Topics: Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methionine; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2007 |
Grading of brain glioma with 1-11C-acetate PET: comparison with 18F-FDG PET.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.
Topics: Adolescent; Adult; Aged; Biopsy; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Astrocytoma; Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Kidney Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate; Teratoma; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
[18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis].
Topics: Adult; Aged; Aged, 80 and over; Animals; Brain Neoplasms; Cell Division; Cytogenetics; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Karyotyping; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Tomography, Emission-Computed | 1994 |
Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures.
Topics: Adolescent; Adult; Brain; Brain Diseases; Brain Mapping; Brain Neoplasms; Child; Child, Preschool; Electronic Data Processing; Epilepsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Methionine; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
18F alpha-methyl tyrosine PET studies in patients with brain tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.
Topics: Adolescent; Adult; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
Blood flow and metabolism of oligodendrogliomas: a positron emission tomography study with kinetic analysis of 18F-fluorodeoxyglucose.
Topics: Adult; Aged; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Oligodendroglioma; Regional Blood Flow; Tomography, Emission-Computed | 1999 |
FDG-PET in the staging work-up of patients with suspected intracranial metastatic tumors.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors.
Topics: Adolescent; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Methionine; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radiopharmaceuticals; Temozolomide; Tomography, Emission-Computed | 2000 |
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Topics: Adult; Aged; Brachytherapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Injections, Intralesional; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Receptors, Somatostatin; Sensitivity and Specificity; Treatment Outcome; World Health Organization; Yttrium Radioisotopes | 2002 |
549 other study(ies) available for fluorodeoxyglucose f18 and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Detection of clinically silent brain lesions in [18F]FDG PET/CT study in oncological patients: analysis of over 10,000 studies.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Brain; Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neuroimaging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Imaging PD-L1 Expression in Melanoma Brain Metastases.
Topics: B7-H1 Antigen; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction.
Topics: Brain; Brain Neoplasms; Carbon Radioisotopes; Craniotomy; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Methionine; Multimodal Imaging; Positron-Emission Tomography; Racemethionine; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
First-in-human assessment of the novel LAT1 targeting PET probe
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Large Neutral Amino Acid-Transporter 1; Male; Molecular Probes; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2022 |
BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in Lung Cancer Patients.
Topics: Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Differentiating solitary brain metastases from glioblastoma by radiomics features derived from MRI and 18F-FDG-PET and the combined application of multiple models.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
First-in-Man Noninvasive Initial Diagnostic Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET With 18 F-Fludarabine and l -[methyl- 11 C]Methionine.
Topics: Adrenal Cortex Hormones; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Methionine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Vidarabine | 2022 |
Delayed [ 18 F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From Radionecrosis.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Necrosis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2022 |
18 F-FDOPA and MRI Findings in a Case of Multiple Sclerosis.
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Multicenter clinical radiomics-integrated model based on [
Topics: alpha-Thalassemia; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Intellectual Disability; Magnetic Resonance Imaging; Mutation; Retrospective Studies; X-linked Nuclear Protein | 2023 |
What is the effect of tumor diameter, lymph node metastases, and SUVmax value on prognosis in limited-stage small cell lung cancer?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma.
Topics: Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Glycolysis; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Male; Pyruvates; Rats; Rats, Wistar | 2023 |
Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and
Topics: Astrocytoma; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Isocitrate Dehydrogenase; Mutation; Perfusion; Retrospective Studies; Telomerase | 2023 |
What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Topics: Brain Neoplasms; Central Nervous System; Central Nervous System Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Tomography, X-Ray Computed | 2023 |
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Risk Factors | 2023 |
Brain 18 F-FET in a Case of Acute Myeloid Leukemia.
Topics: Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Young Adult | 2023 |
Topics: Adult; Aged; Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Promoter Regions, Genetic; Radiopharmaceuticals; Tumor Suppressor Proteins | 2019 |
What Does Reduced FDG Uptake Mean in High-Grade Gliomas?
Topics: Biological Transport; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography | 2019 |
Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans.
Topics: Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Neural Networks, Computer; Positron-Emission Tomography | 2020 |
Sudden bilateral vision loss due to third ventricular cavernous angioma with intratumoral hemorrhage - case report.
Topics: Blindness; Brain Neoplasms; Craniotomy; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemangioma, Cavernous; Humans; Intracranial Hemorrhages; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Third Ventricle; Visual Acuity; Visual Field Tests; Visual Fields | 2019 |
Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT.
Topics: Adolescent; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Neoplasm Metastasis; Neoplasm Staging; Neurons; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2020 |
Risk stratification of symptomatic brain metastases by clinical and FDG PET parameters for selective use of prophylactic cranial irradiation in patients with extensive disease of small cell lung cancer.
Topics: Brain Neoplasms; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Risk Assessment; Small Cell Lung Carcinoma | 2020 |
Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET.
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiosurgery | 2020 |
Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Carcinogenesis; Central Nervous System Neoplasms; Cerebrospinal Fluid Proteins; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Interferon Regulatory Factors; Ki-67 Antigen; L-Lactate Dehydrogenase; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Retrospective Studies; Steroids | 2020 |
BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young.
Topics: Adolescent; Brain Neoplasms; Carbon Radioisotopes; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Male; Methionine; Mutation; Neoplasms, Neuroepithelial; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals | 2020 |
Can FDG-PET/MR help to overcome limitations of sequential MRI and PET-FDG for differential diagnosis between recurrence/progression and radionecrosis of high-grade gliomas?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case.
Topics: Brain Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplastic Syndromes, Hereditary; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Pilot Study: Texture Analysis of PET Imaging Demonstrates Changes in
Topics: Brain; Brain Neoplasms; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pilot Projects; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2021 |
Long-term Survival with 18-Fluorodeoxyglucose Positron Emission Tomography-directed Therapy in Non-small Cell Lung Cancer with Synchronous Solitary Brain Metastasis.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2021 |
Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [
Topics: Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Diazonium Compounds; Fluorescent Antibody Technique; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycolysis; Humans; Membrane Proteins; Radiopharmaceuticals; Sulfanilic Acids; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2021 |
FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Meningeal Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Spinal Cord Neoplasms; Temozolomide | 2021 |
Hypermetabolic Cerebral Metastases of Cardiac Myxoma on FDG PET/CT.
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Myxoma; Positron Emission Tomography Computed Tomography | 2021 |
In vivo selection of the MDA-MB-231br/eGFP cancer cell line to obtain a clinically relevant rat model for triple negative breast cancer brain metastasis.
Topics: Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Green Fluorescent Proteins; Humans; Magnetic Resonance Imaging; Neoplasm Transplantation; Rats; Rats, Nude; Serial Passage; Triple Negative Breast Neoplasms | 2020 |
The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.
Topics: Brain Neoplasms; Case-Control Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Glucose; Humans; Isocitrate Dehydrogenase; Mutation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tumor Cells, Cultured | 2021 |
Efficacy of Positron Emission Tomography in distinguishing brain tumours from inflammation.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, GABA | 2020 |
Primary Central Nervous System Lymphoma Revealed by 68Ga-FAPI and 18F-FDG PET/CT.
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Quinolines | 2021 |
Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Perfusion; Positron-Emission Tomography; Pyruvic Acid; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, X-Ray Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
Topics: Brain Neoplasms; Central Nervous System; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Positron-Emission Tomography; Retrospective Studies; Spin Labels | 2021 |
Osteogenic and brain metastases after non-small cell lung cancer resection.
Topics: Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Quality of Life; Retrospective Studies | 2021 |
Rare Brain Metastasis in Parotid Adenoid Cystic Carcinoma Detected on 68Ga-PSMA PET/CT.
Topics: Brain Neoplasms; Carcinoma, Adenoid Cystic; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2021 |
Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Topics: Adult; Astrocytoma; Bone Neoplasms; Brain Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging | 2017 |
Simultaneous maximum a posteriori longitudinal PET image reconstruction.
Topics: Algorithms; Brain Neoplasms; Fluorodeoxyglucose F18; Head; Humans; Image Processing, Computer-Assisted; Neuroimaging; Phantoms, Imaging; Positron-Emission Tomography | 2017 |
Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Injuries; Retrospective Studies; Tomography, X-Ray Computed | 2018 |
A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2017 |
Rare Ileal Ewing Sarcoma/Primitive Neuroectodermal Tumor on 18F-FDG PET/CT.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ileal Neoplasms; Neuroectodermal Tumors, Primitive; Positron Emission Tomography Computed Tomography; Sarcoma, Ewing; Young Adult | 2017 |
Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.
Topics: Brain Neoplasms; Diagnosis, Differential; Discriminant Analysis; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2017 |
Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2017 |
18F-FDG PET/CT in primary brain lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Whole Body Imaging | 2018 |
Simultaneous Brain and Lung Histiocytic Sarcoma Revealed on 18F-FDG PET/CT.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Histiocytic Sarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography | 2018 |
Correlation of Glioma Proliferation and Hypoxia by Luciferase, Magnetic Resonance, and Positron Emission Tomography Imaging.
Topics: Animals; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Humans; Luciferases; Luminescent Proteins; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2018 |
Remote effects in the ipsilateral thalamus and/or contralateral cerebellar hemisphere using FDG PET in patients with brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thalamus | 2018 |
In vivo characterization of brain metabolism by
Topics: Adaptor Proteins, Signal Transducing; Animals; Aspartic Acid; Brain; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; gamma-Aminobutyric Acid; Glioma; Glucose; Glutamic Acid; Humans; Male; Mice; Neoplasm Transplantation; Oxidation-Reduction; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Repressor Proteins | 2018 |
Prediction of Overall Survival Based on Isocitrate Dehydrogenase 1 Mutation and 18F-FDG Uptake on PET/CT in Patients With Cerebral Gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis | 2018 |
The roles of
Topics: Acetates; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Cell Differentiation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2018 |
A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carbon Radioisotopes; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Neurosurgical Procedures; Positron-Emission Tomography; Prospective Studies; Surgery, Computer-Assisted; Young Adult | 2018 |
99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Technetium | 2018 |
Performance Comparison Between
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Small Cell Lung Carcinoma | 2018 |
Diagnostic value of
Topics: Adult; Aged; Aged, 80 and over; Austria; Brain Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Switzerland | 2018 |
Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Impact of
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Heavy Ion Radiotherapy; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiotherapy, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Tumor Burden | 2018 |
Is It Possible to Establish the Extent of Resection of Glioblastoma With 18F-Fluorocholine PET/CT?
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
[
Topics: Animals; Bevacizumab; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioblastoma; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Temozolomide; Tissue Distribution; Treatment Outcome; Tumor Burden | 2019 |
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2018 |
Pineal Anaplastic Ependymoma With Multifocal Intradural Extramedullary Metastases on MRI and 18FDG-PET.
Topics: Brain Neoplasms; Ependymoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Pineal Gland; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2018 |
A smart and operator independent system to delineate tumours in Positron Emission Tomography scans.
Topics: Algorithms; Brain Neoplasms; Diagnosis, Computer-Assisted; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Observer Variation; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2018 |
11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Patient Care Planning; Positron-Emission Tomography; Progression-Free Survival; Radiopharmaceuticals; Treatment Outcome; Young Adult | 2019 |
Hypermetabolism Caused by Seizure Mimicking Tumor Recurrence.
Topics: Adult; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seizures | 2018 |
FDG PET/MRI Coregistration Helps Predict Response to Gamma Knife Radiosurgery in Patients With Brain Metastases.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Treatment Outcome | 2019 |
Subacute Venous Infarct Mimicking Cerebral Metastasis in 18F-FDG PET/CT.
Topics: Aged; Brain Infarction; Brain Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2019 |
Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.
Topics: Animals; Brain; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rats; Rats, Nude | 2018 |
Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
The validity of
Topics: Animals; Biomarkers; Biopsy; Blood-Brain Barrier; Brain; Brain Neoplasms; Carbazoles; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genotype; Humans; Indoles; Inflammation; Ligands; Loperamide; Multiple Sclerosis; Positron-Emission Tomography; Protein Binding; Purines; Receptors, GABA; Reproducibility of Results; Verapamil | 2019 |
Pattern of FDG and MET Distribution in High- and Low-Grade Gliomas on PET Images.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Retrospective Studies | 2019 |
Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma.
Topics: Adolescent; Brain Neoplasms; Cavernous Sinus; Fluorodeoxyglucose F18; Humans; Male; Neurocytoma; Peptides, Cyclic; Receptors, Somatostatin; Sella Turcica; Somatostatin; Vasopressins | 2019 |
Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
Comparison of dual-time point 18F-FDG PET/CT tumor-to-background ratio, intraoperative 5-aminolevulinic acid fluorescence scale, and Ki-67 index in high-grade glioma.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Brain Neoplasms; Cell Proliferation; Female; Fluorescent Dyes; Fluorodeoxyglucose F18; Glioma; Humans; Intraoperative Period; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe.
Topics: Animals; Brain Neoplasms; Diagnostic Imaging; Fluorodeoxyglucose F18; Gold; HEK293 Cells; Humans; Iodine Radioisotopes; Metal Nanoparticles; Mice; Optical Imaging; Organ Specificity; Positron Emission Tomography Computed Tomography | 2019 |
Evaluation of Glycolytic Response to Multiple Classes of Anti-glioblastoma Drugs by Noninvasive Measurement of Pyruvate Kinase M2 Using [
Topics: Antineoplastic Agents; Brain Neoplasms; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Positron-Emission Tomography; Pyruvate Kinase; Radiopharmaceuticals; Tumor Cells, Cultured | 2020 |
The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors.
Topics: Adult; Ammonia; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Phenotype; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2019 |
MRI and PET image fusion using the nonparametric density model and the theory of variable-weight.
Topics: Algorithms; Alzheimer Disease; Brain; Brain Mapping; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Normal Distribution; Positron-Emission Tomography; Principal Component Analysis | 2019 |
Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Disease Progression; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Time Factors | 2019 |
FDG PET/CT Findings of Unsuspected Pulmonary Epithelioid Angiosarcoma Manifested as a Brain Metastasis.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Incidental Findings; Lung Neoplasms; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography | 2019 |
Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
Radiomics signature based on FDG-PET predicts proliferative activity in primary glioma.
Topics: Adult; Algorithms; Brain Neoplasms; Cell Proliferation; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glioma; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2019 |
Organizing intracerebral hematoma mimicking a recurrent brain tumor on FDG-PET.
Topics: Adolescent; Brain Neoplasms; Cerebral Hemorrhage; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematoma; Humans; Male; Middle Aged; Positron-Emission Tomography | 2013 |
Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Topics: Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Glucose corrected standardized uptake value (SUVgluc) in the evaluation of brain lesions with 18F-FDG PET.
Topics: Adolescent; Adult; Aged; Biological Transport; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Young Adult | 2013 |
[Application of positron-emission tomography-magnetic resonance imaging fusion in biopsy and resection of gliomas].
Topics: Adult; Aged; Biopsy; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Young Adult | 2013 |
False-positive finding of brain metastasis on (18)F-FDG PET imaging due to early subacute ischemic stroke.
Topics: Brain Ischemia; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiography; Stroke | 2013 |
Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Reproducibility of Results; Stereotaxic Techniques | 2013 |
18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.
Topics: Alanine; Animals; Brain Neoplasms; Cell Line, Tumor; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Triazoles; Tyrosine | 2013 |
Impact of automated hotspot detection for (18)FET PET-guided stereotactic biopsy.
Topics: Adult; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2013 |
¹⁸F-FDG PET/CT in HIV-related central nervous system pathology.
Topics: Adult; Aged; AIDS Arteritis, Central Nervous System; AIDS-Related Opportunistic Infections; Brain Neoplasms; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, AIDS-Related; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 2013 |
The comparison of 13N-ammonia and 18F-FDG in the evaluation of untreated gliomas.
Topics: Adolescent; Adult; Aged; Ammonia; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Positron-Emission Tomography; Young Adult | 2013 |
Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2013 |
Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2013 |
Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.
Topics: Adolescent; Brain Neoplasms; Child; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neoplasm Grading; Neuroimaging; Permeability; Radionuclide Imaging; Research Report | 2013 |
Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
Topics: Animals; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Brain Neoplasms; Dacarbazine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Injections, Intraventricular; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasms, Experimental; Temozolomide; Tomography, Emission-Computed; Treatment Outcome; Tumor Burden | 2013 |
(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Coordination Complexes; Copper Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thiosemicarbazones; Young Adult | 2014 |
Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2014 |
Small cell carcinoma of the thyroid gland with a solid brain metastasis detected by F-18-FDG PET/CT.
Topics: Aged; Brain Neoplasms; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Thyroid Neoplasms | 2014 |
Examining changes in [18 F]FDG and [18 F]FLT uptake in U87-MG glioma xenografts as early response biomarkers to treatment with the dual mTOR1/2 inhibitor AZD8055.
Topics: Animals; Biomarkers, Tumor; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Mice; Mice, Nude; Morpholines; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neuroimaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tissue Distribution | 2014 |
Molecular and metabolic pattern classification for detection of brain glioma progression.
Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Protons; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Support Vector Machine | 2014 |
[Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery | 2014 |
Direct parametric image reconstruction of rapid multi-tracer PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Mice; Models, Biological; Neoplasms, Experimental; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Quantitative imaging values of CT, MR, and FDG-PET to differentiate pineal parenchymal tumors and germinomas: are they useful?
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Germinoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Pineal Gland; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
Asymptomatic solitary cerebral metastasis from papillary carcinoma thyroid: 131I SPECT/CT for accurate staging.
Topics: Asymptomatic Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2014 |
Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Inbred F344; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2015 |
The diagnostic role of (18)F-FDG PET for primary central nervous system lymphoma.
Topics: Adrenal Cortex Hormones; Aged; Biological Transport; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2014 |
Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
Topics: Adolescent; Adult; Ammonia; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
(68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.
Topics: Adult; Aged; Antigens, CD34; Brain; Brain Neoplasms; Choroid Plexus; Coordination Complexes; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glioma; Humans; Immunohistochemistry; Integrin alphaVbeta3; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Peptides, Cyclic; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2014 |
Crossed cerebellar diaschisis due to cerebral diffuse large B cell lymphoma on 18F-FDG PET/CT.
Topics: Brain Neoplasms; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
18F-fluoroethylcholine (18F-Cho) PET/MRI functional parameters in pediatric astrocytic brain tumors.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Child; Choline; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine | 2015 |
Recurrent ureteric transitional cell carcinoma presenting as an isolated brain metastasis: incidental detection with 18F-FDG PET/CT.
Topics: Aged; Brain Neoplasms; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ureteral Neoplasms | 2015 |
FDG-PET/CT of schwannomas arising in the brachial plexus mimicking lymph node metastasis: report of two cases.
Topics: Aged; Brachial Plexus; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neurilemmoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
A tri-modality image fusion method for target delineation of brain tumors in radiotherapy.
Topics: Aged; Algorithms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, Emission-Computed | 2014 |
Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
13N-ammonia combined with 18F-FDG could discriminate between necrotic high-grade gliomas and brain abscess.
Topics: Adult; Aged; Ammonia; Brain Abscess; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Nitrogen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Multimodal Imaging; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Assessment of grading in newly-diagnosed glioma using 18F-fluorothymidine PET/CT.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
FDG and (82)Rb PET/MRI features of brain metastasis of breast cancer.
Topics: Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes | 2015 |
Asymmetric muscle activity on (18)F-FDG PET/CT.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Muscle, Skeletal; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
Topics: Adult; Aged; Biological Transport; Blood Glucose; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm, Residual; Positron-Emission Tomography; Recurrence | 2015 |
Global and regional brain glucose metabolism decline after systemic chemotherapy.
Topics: Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2015 |
Lean body mass correction of standardized uptake value in simultaneous whole-body positron emission tomography and magnetic resonance imaging.
Topics: Adult; Aged; Body Composition; Body Mass Index; Brain Neoplasms; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Obesity; Positron-Emission Tomography; Prospective Studies; Whole Body Imaging | 2015 |
Determination of the unmetabolised (18)F-FDG fraction by using an extension of simplified kinetic analysis method: clinical evaluation in paragangliomas.
Topics: Brain Neoplasms; Case-Control Studies; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
Topics: Aged; Biomarkers, Tumor; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Receptors, GABA; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2015 |
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Unnecessary Procedures | 2015 |
Estimation of Tumor Volumes by 11C-MeAIB and 18F-FDG PET in an Orthotopic Glioblastoma Rat Model.
Topics: Animals; beta-Alanine; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunohistochemistry; Male; Neoplasm Transplantation; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude | 2015 |
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma.
Topics: Adult; Aged; Brain Neoplasms; Demography; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Young Adult | 2015 |
Volumetric Analysis of F-18-FET-PET Imaging for Brain Metastases.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tumor Burden; Tyrosine | 2015 |
Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Pseudoprogression after proton radiotherapy for pediatric low grade glioma.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Perfusion Imaging; Positron-Emission Tomography; Proton Therapy; Radiopharmaceuticals | 2015 |
The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cohort Studies; Disease Progression; Drug Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiotherapy; ROC Curve | 2015 |
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors.
Topics: Adult; Biomarkers, Tumor; Brain Neoplasms; Case-Control Studies; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Male; Middle Aged; Oxygen Consumption; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Effectiveness of the addition of the brain region to the FDG-PET/CT imaging area in patients with suspected or diagnosed lung cancer.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Opsoclonus-Myoclonus Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Tomography, X-Ray Computed; Young Adult | 2016 |
A Clinical Pitfall: Optimal Management of Single Dural-based Metastatic Carcinoma of the Breast Mimicking Meningioma.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Middle Aged; Positron-Emission Tomography | 2015 |
Evidence of 18F-FCH Uptake in Human T98G Glioblastoma Cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioblastoma; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
Topics: Adult; Aged; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries | 2016 |
Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Perfusion Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2016 |
(31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results.
Topics: Adult; Brain; Brain Neoplasms; Cell Differentiation; Computer Simulation; Equipment Design; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Male; Models, Theoretical; Phantoms, Imaging; Phosphorus; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Signal-To-Noise Ratio | 2016 |
A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Disease Models, Animal; Fluorodeoxyglucose F18; Glioblastoma; Heterografts; Humans; Image Processing, Computer-Assisted; Luminescent Measurements; Mice; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Topics: Adult; Aged; Animals; Brain Neoplasms; Case-Control Studies; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glioblastoma; Glutamic Acid; Heterografts; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tomography, X-Ray Computed; Tyrosine | 2016 |
18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors.
Topics: Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?
Topics: Acetates; Antigens, Surface; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Ethylenediamines; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |
Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Artifacts; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2016 |
Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Motion; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2016 |
18F-NaF PET/CT Imaging of Brain Metastases.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2016 |
Response to: Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics.
Topics: Bias; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Performance of 18F-FET-PET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: inherent bias in meta-analysis not revealed by quality metrics.
Topics: Bias; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2016 |
Brain-Only Metastases Seen on FDG PET as First Relapse of Papillary Thyroid Carcinoma Two Years Post-Thyroidectomy.
Topics: Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2016 |
Differences in Uptake of 18F-FDG and 11C-Choline in a Case of Acute Myeloid Leukemia.
Topics: Adult; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunohistochemistry; Ki-67 Antigen; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Tissue Distribution | 2016 |
Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Glioblastoma; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Oxygen; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
Topics: Adult; Aged; Brain Neoplasms; Child; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Glioma; Humans; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging; Young Adult | 2017 |
"Comment on Hatzoglou et al.: Dynamic contrast-enhanced MRI perfusion vs 18FDG PET/CT in differentiating brain tumor progression from radiation injury"-Reply.
Topics: Brain Neoplasms; Cranial Irradiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiation Injuries | 2017 |
Comment on Hatzoglou et al: Dynamic contrast-enhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury.
Topics: Brain Neoplasms; Cranial Irradiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiation Injuries | 2017 |
Neurosarcoidosis on FET and FDG PET/CT.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2017 |
FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach.
Topics: Animals; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Animal; Mice; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2017 |
An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using
Topics: Adult; Algorithms; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values | 2017 |
FDG PET/MR Imaging Coregistration Helps Predict Survival in Patients with Glioblastoma and Radiologic Progression after Standard of Care Treatment.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Virginia | 2017 |
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Positron Emission Tomography Computed Tomography | 2017 |
Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer.
Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Whole-Body Counting | 2008 |
FDG positron emission tomography imaging of drug-induced pneumonitis.
Topics: Aged; Anxiety Disorders; Brain Neoplasms; Breast Neoplasms; Dibenzothiazepines; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pneumonia; Positron-Emission Tomography; Quetiapine Fumarate; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
11C-acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PET.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carbon Isotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography | 2008 |
Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas.
Topics: Boranes; Brain Neoplasms; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Phenylalanine; Positron-Emission Tomography; Retrospective Studies; Statistics, Nonparametric | 2008 |
FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Positron-Emission Tomography | 2008 |
Relationship between PET-FDG and MRI apparent diffusion coefficients in brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Diffusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2009 |
No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
Topics: Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Hexokinase; Humans; Immunoenzyme Techniques; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2008 |
Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cerebrovascular Circulation; Cognition Disorders; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Conformal; Young Adult | 2009 |
Accuracy of whole-body FDG-PET/CT for detecting brain metastases from non-central nervous system tumors.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Imaging in glioma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Improved discrimination of benign and malignant lesions on FDG PET/CT, using comparative activity ratios to brain, basal ganglia, or cerebellum.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Extrapulmonary small cell carcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans.
Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Craniotomy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Topotecan | 2008 |
Technetium Tc99m tetrofosmin single-photon emission CT for the assessment of glioma proliferation.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glioma; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
Increased 18F-FDG uptake in the posterior ocular bulb is associated with brain metastasis: a retrospective study.
Topics: Brain Neoplasms; Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2008 |
A case of central nervous system lymphomatoid granulomatosis; characteristics of PET imaging and pathological findings.
Topics: Aged; Brain Neoplasms; Cerebral Cortex; Fluorodeoxyglucose F18; Humans; Lymphomatoid Granulomatosis; Male; Positron-Emission Tomography; Treatment Outcome | 2009 |
Pathophysiological mechanism of ipsilateral cerebral and brainstem hemiatrophy in basal ganglia germ cell tumors: case report.
Topics: Atrophy; Brain; Brain Neoplasms; Brain Stem; Cerebral Angiography; Cerebrum; Child; Fluorodeoxyglucose F18; Functional Laterality; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography | 2009 |
18F-fluorodeoxyglucose positron emission tomography imaging in brain tumours: the Western Australia positron emission tomography/cyclotron service experience.
Topics: Adult; Aged; Brain Neoplasms; Cyclotrons; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2008 |
Utility of brain FDG-PET in primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[The usefulness of whole body FDG-PET/CT in patients with brain metastasis].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET-CT imaging in recurrent cerebral gliosarcoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Gliosarcoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma.
Topics: Adult; Aged; Brain Neoplasms; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2009 |
F-18 flurodeoxyglucose negative, F-18 fluoride accumulating in a brain metastasis in a treated case of carcinoma of the breast.
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Female; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Comparison of two commercial whole body PET systems based on LSO and BGO crystals respectively for brain imaging.
Topics: Algorithms; Brain; Brain Neoplasms; Contrast Media; Crystallization; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Models, Statistical; Normal Distribution; Phantoms, Imaging; Positron-Emission Tomography; Reproducibility of Results; Scattering, Radiation; Tomography, X-Ray Computed | 2009 |
Modification of glucose metabolism in radiation-induced brain injury areas using cervical spinal cord stimulation.
Topics: Adult; Afferent Pathways; Aged; Brain; Brain Damage, Chronic; Brain Mapping; Brain Neoplasms; Cerebrovascular Circulation; Cervical Vertebrae; Electric Stimulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Injuries; Radiotherapy; Sensitivity and Specificity; Spinal Cord | 2009 |
Occurrence of basal ganglia germ cell tumors without a mass.
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Agents; Asian People; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Brain Stem; Calcinosis; Child; Dementia; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Paresis; Positron-Emission Tomography; Radiotherapy | 2009 |
The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood.
Topics: Adolescent; Astrocytoma; Brain Neoplasms; Cell Proliferation; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution | 2009 |
Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Kinetics; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2009 |
[Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging].
Topics: Acetates; Adolescent; Adult; Aged; Brain Abscess; Brain Neoplasms; Carbon; Carbon Radioisotopes; Child; Craniopharyngioma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Young Adult | 2009 |
Delayed acquisition and hyperglycemia improve brain metastasis detection on F-18 FDG PET.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors | 2009 |
The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2009 |
Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Pinealoma; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Soft Tissue Neoplasms | 2009 |
[PTV--PET traced volume?].
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography | 2009 |
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective study.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Analysis; Survival Rate | 2009 |
18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of primary intracranial histiocytic sarcoma in a dog.
Topics: Animals; Brain Neoplasms; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Histiocytic Sarcoma; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2009 |
Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Disease Progression; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2010 |
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain Neoplasms; Caspases; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Synergism; Fluorodeoxyglucose F18; Glioblastoma; Humans; Luminescent Measurements; Mice; Mice, Nude; Paclitaxel; Positron-Emission Tomography; TNF-Related Apoptosis-Inducing Ligand; Treatment Outcome; Tumor Burden; Tumor Suppressor Protein p53; X-Ray Microtomography; Xenograft Model Antitumor Assays | 2009 |
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2010 |
Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging.
Topics: Adult; Aged; Brain Injuries; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2010 |
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2009 |
Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Severity of Illness Index; Survival Analysis | 2010 |
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brain Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Melanoma; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Gliosarcoma; Image Processing, Computer-Assisted; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2010 |
Temporal neocortical origin of pilomotor seizures in association with an infiltrating glioma: a case confirmed by intracranial electroencephalography monitoring.
Topics: Astrocytoma; Biopsy; Brain Neoplasms; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Piloerection; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
[Fluoroethylthyrosine 18F PET in the detection of brain tumours].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2010 |
(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases.
Topics: Adolescent; Brain Neoplasms; Child, Preschool; Diagnosis, Differential; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2010 |
Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.
Topics: Adolescent; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Epilepsy; Female; Fluorodeoxyglucose F18; Ganglioglioma; Humans; Image Processing, Computer-Assisted; Infant; Male; Malformations of Cortical Development; Methionine; Neoplasms, Neuroepithelial; Neurosurgical Procedures; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Detection of papillary thyroid cancer brain metastasis with FDG-PET/CT.
Topics: Aged; Brain Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2010 |
Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Tyrosine | 2010 |
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases.
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
Topics: Adolescent; Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Incidental Findings; Infant; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Sensitivity and Specificity | 2010 |
Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors.
Topics: Adolescent; Belgium; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Incidental Findings; Infant; Magnetic Resonance Imaging; Male; Methionine; Neuronavigation; Positron-Emission Tomography; Postoperative Complications; Reoperation; Retrospective Studies; Sensitivity and Specificity | 2010 |
Retrospective evaluation of PET-MRI registration algorithms.
Topics: Algorithms; Brain; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Lymphoma; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2011 |
The efficacy of dual time point F-18 FDG PET imaging for grading of brain tumors.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Time Factors; Young Adult | 2010 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine | 2010 |
Limitation of F-18 fluorodeoxyglucose positron emission tomography in the detection of metastatic adenocarcinoma of brain combining intratumoral hemorrhage.
Topics: Adenocarcinoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Intracranial Hemorrhages; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography | 2010 |
Detection of histological anaplasia in gliomas with oligodendroglial components using positron emission tomography with (18)F-FDG and (11)C-methionine: report of two cases.
Topics: Adult; Anaplasia; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Oligodendroglia; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2011 |
Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Paresis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy | 2010 |
[Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals | 2010 |
18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contrast Media; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Microcirculation; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels; Stereotaxic Techniques | 2010 |
Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2011 |
Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2011 |
Intestinal metastasis from non-small-cell lung cancer initially detected by ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biopsy; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Double-Balloon Enteroscopy; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Jejunal Neoplasms; Lung; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
Topics: Adult; Aged; Brain; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography | 2012 |
Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Seizures and radionecrosis from non-small-cell lung cancer presenting as increased fluorodeoxyglucose uptake on positron emission tomography.
Topics: Anticonvulsants; Brain Injuries; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cranial Irradiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Seizures | 2011 |
Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging.
Topics: Animals; Autoradiography; Brain Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Glioma; Locomotion; Male; Nervous System Diseases; Neurologic Examination; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Survival Analysis; Touch; Visual Perception | 2011 |
Brain tumors.
Topics: Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
18F-FDG PET detection of spinal leptomeningeal metastases from cerebral glioblastoma multiforme.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Meningeal Neoplasms; Middle Aged; Positron-Emission Tomography; Spinal Cord | 2011 |
Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Diffusion; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; ROC Curve | 2011 |
Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Inflammation; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methionine; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2011 |
Focal cerebral hypermetabolism due to nonconvulsive status epilepticus mimicking metastasis in staging a patient with lung cancer by FDG PET/CT.
Topics: Aged; Brain Diseases, Metabolic; Brain Neoplasms; Diagnosis, Differential; Epilepsy, Generalized; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
Topics: Animals; Brain Neoplasms; Disease Models, Animal; Dose Fractionation, Radiation; Feasibility Studies; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Mice, Nude; Positron-Emission Tomography; Radiation Injuries, Experimental; Radiation Tolerance; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Xenograft Model Antitumor Assays | 2011 |
Usefulness of (13)N-NH (3) PET in the evaluation of brain lesions that are hypometabolic on (18)F-FDG PET.
Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Young Adult | 2011 |
Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Young Adult | 2011 |
Dual-modality brain PET-CT image segmentation based on adaptive use of functional and anatomical information.
Topics: Adolescent; Adult; Aged; Algorithms; Brain; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult | 2012 |
F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; India; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
Modification of loco-regional microenvironment in brain tumors by spinal cord stimulation. Implications for radio-chemotherapy.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Combined Modality Therapy; Electric Stimulation; Female; Fluorodeoxyglucose F18; Humans; Karnofsky Performance Status; Male; Middle Aged; Middle Cerebral Artery; Neurosurgical Procedures; Oxygen Consumption; Polarography; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler, Transcranial; Young Adult | 2012 |
Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience.
Topics: Adult; Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Italy; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neurosurgical Procedures; Odds Ratio; Pneumonectomy; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Imaging ¹⁸F-fluorodeoxy glucose/¹¹C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema.
Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Meningioma; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
[Potential of PET in the diagnosis and the assessment of treatment effectiveness in progressive malignant glioma].
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Incidental finding of multiple cavernous angiomas on FDG PET/CT.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Incidental Findings; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy.
Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Radiation Injuries; Tomography, X-Ray Computed; Young Adult | 2011 |
Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
Topics: Animals; Biological Transport; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Inositol; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Positron-Emission Tomography; Radiochemistry; Transplantation, Heterologous | 2011 |
Pain-related F-18 FDG uptake of the corrugator supercilii muscles in PET/CT.
Topics: Adult; Back Pain; Brain Neoplasms; Diagnosis, Differential; Facial Muscles; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals | 2012 |
Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.
Topics: Adult; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2012 |
Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Demography; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2012 |
F-18 FDG and C-11 methionine PET/CT in intracranial dural metastases.
Topics: Brain Neoplasms; Dura Mater; Female; Fluorodeoxyglucose F18; Humans; Meningeal Neoplasms; Methionine; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Assessment of rhabdoid brain tumor by F-18 FDG PET, C-11 methionine PET and MRI.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Positron-Emission Tomography; Rhabdoid Tumor | 2012 |
Primary intracranial adenoid cystic carcinoma.
Topics: Adult; Brain Neoplasms; Carcinoma, Adenoid Cystic; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gallium Radioisotopes; Hallucinations; Headache; Humans; Magnetic Resonance Imaging; Memory Disorders; Neurosurgical Procedures; Radiopharmaceuticals; Radiosurgery | 2012 |
¹⁸F-FDG PET/CT imaging for mixed germ cell tumor in the pineal region.
Topics: Adolescent; Brain Neoplasms; Choriocarcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pineal Gland; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Tomography, X-Ray Computed | 2012 |
In vitro 2-deoxy-2-[18F]fluoro-D-glucose uptake: practical considerations.
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Cell Count; Cell Proliferation; Colorectal Neoplasms; Culture Media; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tumor Cells, Cultured | 2012 |
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Female; Fluorodeoxyglucose F18; Glioma; Humans; Irinotecan; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2012 |
Rare pulmonary primitive neuroectodermal tumor metastasizing to the right atrium: a case report.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Male; Multimodal Imaging; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Radiation induced intraparenchymal meningioma occurring 6 years after CNS germinoma: case report.
Topics: Adolescent; Biopsy; Brain Edema; Brain Neoplasms; Cerebral Cortex; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Germinoma; Humans; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
Diffuse metastases of lung adenocarcinoma with EGFR mutation.
Topics: Adenocarcinoma; Antineoplastic Agents; Brain Neoplasms; ErbB Receptors; Exons; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genes, erbB-1; Humans; Lung Neoplasms; Middle Aged; Mutation; Positron-Emission Tomography; Protein Kinase Inhibitors; Radiography; Sequence Deletion; Spinal Neoplasms | 2012 |
Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Glioma; Humans; Linear Models; Male; Methionine; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Statistics, Nonparametric | 2012 |
SPECT and PET imaging of meningiomas.
Topics: Acetic Acid; Adult; Ammonia; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Meningioma; Nitrogen Radioisotopes; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tyrosine | 2012 |
Uncommon lesions in the internal auditory canal (IAC): review of the literature and case report.
Topics: Adenocarcinoma; Brain Neoplasms; Cerebellopontine Angle; Craniotomy; Ear Canal; Ear Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Hearing Loss; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nausea; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Bone; Tinnitus; Tomography, X-Ray Computed; Vomiting | 2012 |
Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; ROC Curve; Tryptophan | 2012 |
Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging.
Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Glioma; Humans; Leukoencephalopathy, Progressive Multifocal; Male; Middle Aged; Positron-Emission Tomography | 2012 |
Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Data Interpretation, Statistical; Dideoxynucleosides; Disease Progression; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Magnetic Resonance Imaging; Methionine; Neoplasm Transplantation; Neovascularization, Pathologic; Paraffin Embedding; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Xenograft Model Antitumor Assays | 2012 |
Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
Evaluation of an attenuation correction method for PET/MR imaging of the head based on substitute CT images.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Models, Statistical; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Regression Analysis; Tomography, X-Ray Computed | 2013 |
Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spin Labels; Young Adult | 2013 |
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tyrosine; Young Adult | 2012 |
Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Brain Neoplasms; Carcinoembryonic Antigen; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2012 |
Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx.
Topics: Adult; Aged; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Coordination Complexes; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, X-Ray Computed | 2012 |
Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Female; Fluorodeoxyglucose F18; Glioma; Humans; Levodopa; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2013 |
Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Fluorodeoxyglucose F18; Glioma; Humans; Loss of Heterozygosity; Male; Middle Aged; Neoplasm Grading; Oligodendroglia; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Brain Neoplasms; Dacarbazine; Fluorodeoxyglucose F18; Glioblastoma; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Imaging tumor burden in the brain with 89Zr-transferrin.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Mice, Inbred ICR; Radioisotopes; Transferrin; Tumor Burden; Zirconium | 2013 |
Single-scan dual-tracer FLT+FDG PET tumor characterization.
Topics: Brain Neoplasms; Clinical Trials as Topic; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Injections; Positron-Emission Tomography; Time Factors | 2013 |
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2013 |
Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.
Topics: Animals; Autoradiography; Biological Transport; Brain Neoplasms; Cell Hypoxia; Cell Proliferation; Fluorodeoxyglucose F18; Glioma; Glucose; Glucose Transporter Type 1; Hexokinase; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Wistar; Tissue Distribution | 2013 |
A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies.
Topics: Algorithms; Brain Neoplasms; Decision Support Systems, Clinical; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Principal Component Analysis; Sensitivity and Specificity | 2012 |
The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2013 |
[Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
[Initial experiences with adjuvant locoregional radioimmunotherapy using 131I-labeled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV)].
Topics: Adult; Aged; Antibodies, Monoclonal; Brain Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Iodine Radioisotopes; Male; Middle Aged; Radioimmunotherapy; Radioisotopes; Recurrence; Survival Analysis; Tenascin; Time Factors; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in neurology].
Topics: Brain; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Energy Metabolism; Epilepsy; Fluorodeoxyglucose F18; Humans; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Topics: Adolescent; Age Factors; Apoptosis; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Methionine; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuroblastoma; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2002 |
Functional MRI and 18F FDG-positron emission tomography for presurgical planning: comparison with electrical cortical stimulation.
Topics: Adult; Aged; Artifacts; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Electric Stimulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Oxygen; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 2002 |
Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Detection of unknown primary tumours in patients with cerebral metastases using whole-body 18F-flouorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Irradiation | 2002 |
PET imaging using a triple-head gamma camera.
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Oligodendroglioma; Phantoms, Imaging; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Regression Analysis; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[Measurement of brain function by positron emission tomography: from mapping to synaptic function].
Topics: Adult; Brain; Brain Mapping; Brain Neoplasms; Cerebrovascular Circulation; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Moyamoya Disease; Parkinson Disease; Synaptic Transmission; Tomography, Emission-Computed | 2002 |
Initial clinical experience using a new integrated in-line PET/CT system.
Topics: Aged; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Where can FDG-PET contribute most to anatomical imaging problems?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
F-18 FDG brain positron emission tomography and Tl-201 early and delayed SPECT in distinguishing atypical cerebral tumor from cerebral infarction.
Topics: Aged; Brain Neoplasms; Cerebral Infarction; Corpus Striatum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Radiography; Radiopharmaceuticals; Thallium; Tomography, Emission-Computed | 2003 |
Cerebral glucose metabolism in long-term survivors of childhood primary brain tumors treated with surgery and radiotherapy.
Topics: Adolescent; Adult; Brain Neoplasms; Case-Control Studies; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Infant; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Survivors; Tomography, Emission-Computed | 2003 |
[Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Topics: Adult; Animals; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Middle Aged; Sarcoma 180; Tomography, Emission-Computed; Tyrosine | 2002 |
Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Topics: Amino Acids; Animals; Brain Neoplasms; Fluorodeoxyglucose F18; Inflammation; Iodine Radioisotopes; Methyltyrosines; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution; Turpentine; Whole-Body Counting | 2003 |
Prediction of pathology and survival by FDG PET in gliomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Statistics as Topic; Survival Rate; Tomography, Emission-Computed | 2003 |
Assessment of treatment response by autoradiography with (14)C-aminocyclopentane carboxylic acid, (67)Ga-DTPA, and (18)F-FDG in a herpes simplex virus thymidine kinase/ganciclovir brain tumor model.
Topics: Animals; Autoradiography; Brain Neoplasms; Cell Line, Tumor; Cycloleucine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Ganciclovir; Genetic Therapy; Humans; Male; Pentetic Acid; Radionuclide Imaging; Rats; Rats, Inbred F344; Simplexvirus; Thymidine Kinase | 2003 |
[The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Medical Oncology; Neoplasms; Outcome Assessment, Health Care; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron emission tomographic imaging in a patient with persistent hiccups.
Topics: Baclofen; Brain; Brain Neoplasms; Chlorpromazine; Diagnosis, Differential; Fluorodeoxyglucose F18; Hiccup; Humans; Magnetic Resonance Imaging; Male; Multiple Myeloma; Muscle Relaxants, Central; Nifedipine; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Failure | 2004 |
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
Topics: Adolescent; Adult; Aged; Belgium; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Korea; Male; Methionine; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2005 |
[Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Topics: Aged; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Brain; Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Cerebral Cortex; Child; Child, Preschool; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Neuronavigation; Prognosis; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 2004 |
FDG-PET imaging in duodenal cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Brain Neoplasms; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
FDG accumulation in inguinal herniation mimicking metastatic disease.
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hernia, Inguinal; Humans; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
[Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
Topics: Adult; Astrocytoma; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
[Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2004 |
PET imaging I.
Topics: Animals; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; History, 20th Century; History, 21st Century; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
Topics: Acute Disease; Animals; Brain; Brain Injuries; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Necrosis; Neoplasm Recurrence, Local; Quaternary Ammonium Compounds; Radiation Injuries, Experimental; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tyrosine | 2004 |
Correlation of molecular genetics with molecular and morphological imaging in gliomas with an oligodendroglial component.
Topics: Adult; Aged; Alleles; Blood-Brain Barrier; Brain; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lasers; Magnetic Resonance Imaging; Male; Middle Aged; Oligodendroglioma; Prospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2004 |
Methionine and glucose metabolism of central neurocytoma: a PET study.
Topics: Adolescent; Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Headache; Humans; Male; Methionine; Nausea; Neurocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2004 |
[Contribution of PET to the management of patients with low-grade glioma].
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Intracranial germinoma diagnosed by fluorine-18-FDG-PET-guided stereotactic biopsy.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Germinoma; Humans; Magnetic Resonance Imaging; Male; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2004 |
A plea for the elective inclusion of the brain in routine whole-body FDG PET.
Topics: Brain; Brain Diseases; Brain Neoplasms; Communicable Diseases; Fluorodeoxyglucose F18; Humans; Inflammation; Limbic Encephalitis; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Whole-Body Counting | 2005 |
Modern multimodal neuroimaging for radiosurgery: the example of PET scan integration.
Topics: Adenoma; Brain; Brain Neoplasms; Contrast Media; Energy Metabolism; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuronavigation; Phantoms, Imaging; Pituitary Neoplasms; Positron-Emission Tomography; Quality Control; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Gamma knife radiosurgery for patients with multiple cerebral metastases.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neuronavigation; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Survival Analysis | 2004 |
Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis.
Topics: Brain; Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Thallium | 2005 |
Functional imaging of a large demyelinating lesion.
Topics: Adult; Brain; Brain Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Methionine; Multiple Sclerosis; Positron-Emission Tomography; Radiography | 2005 |
Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Whole Body Imaging | 2005 |
Positron emission tomography for the early postsurgical evaluation of pediatric brain tumors.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Methionine; Positron-Emission Tomography; Retrospective Studies | 2005 |
Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemma.
Topics: Adult; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Severity of Illness Index | 2005 |
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Topics: Animals; Boron Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glycopeptides; Metabolic Clearance Rate; Molecular Probe Techniques; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine | 2005 |
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2005 |
Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma.
Topics: Aged; Brain Neoplasms; Carcinoma; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Meningioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2005 |
Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas.
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity | 2005 |
Usefulness of [18F]FDG-PET kinetic analysis in non-enhancing primary central nervous system lymphoma: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lymphoma, B-Cell; Middle Aged; Models, Biological; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2005 |
Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT.
Topics: Adolescent; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lower Extremity; Meningioma; Pain; Positron-Emission Tomography; Radiopharmaceuticals; Sacrum; Spasm; Spinal Neoplasms; Tomography, X-Ray Computed | 2005 |
[Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
Topics: Adult; Astrocytoma; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Methyltyrosines; Middle Aged; Radioisotopes; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
FDG-PET on irradiated brain tumor: ten years' summary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma; Child; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2006 |
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine | 2006 |
Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.
Topics: Adolescent; Brain Neoplasms; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Incidence; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Spinal Cord Neoplasms; Survival Analysis | 2006 |
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Topics: Adolescent; Adult; Aged; Biopsy; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve | 2006 |
Modification of glucose metabolism in brain tumors by using cervical spinal cord stimulation.
Topics: Adult; Aged; Blood Glucose; Brain Neoplasms; Cerebral Cortex; Electric Stimulation Therapy; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oxygen Consumption; Positron-Emission Tomography; Regional Blood Flow; Spinal Cord | 2006 |
18F-FET PET differentiation of ring-enhancing brain lesions.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Temozolomide; Treatment Outcome | 2006 |
Delayed [(18)F]FDG PET imaging of central nervous system lymphoma: is PET better than MRI?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma, B-Cell; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
F-18 FDG PET imaging in a primitive neuroectodermal tumor.
Topics: Abdominal Neoplasms; Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.
Topics: Adult; Brain Neoplasms; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunocompetence; Kinetics; Lymphoma; Male; Middle Aged; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
[A case of brain metastasis from gastric cancer involving bilateral middle cerebellar peduncles].
Topics: Adenocarcinoma; Aged; Brain Neoplasms; Cerebellum; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Stomach Neoplasms | 2006 |
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer.
Topics: Aged; Brain; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole Body Imaging | 2006 |
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease Progression; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genotype; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Prospective Studies; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.
Topics: Adult; Astrocytoma; Brain Diseases; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Nitrogen Radioisotopes; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
PET imaging in the surgical management of pediatric brain tumors.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Methionine; Neuronavigation; Positron-Emission Tomography; Radiopharmaceuticals; Stereotaxic Techniques; Surgery, Computer-Assisted; Treatment Outcome | 2007 |
FDG-PET findings of the brain in lymphomatoid granulomatosis.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cyclophosphamide; Doxorubicin; Fluorodeoxyglucose F18; Humans; Lymphomatoid Granulomatosis; Male; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2006 |
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.
Topics: Adult; Aged; Brain; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies | 2007 |
Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphoma, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
Crossed cerebellar diaschisis: a positron emission tomography study with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
Topics: Adult; Aged; Brain Neoplasms; Cerebellar Diseases; Cerebellum; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Topics: Adult; Aged; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Fluorodeoxyglucose F18; Glioma; Humans; Loss of Heterozygosity; Male; Microsatellite Repeats; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2007 |
Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2007 |
Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Head; Humans; Leg; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
Noninvasive quantification of local cerebral metabolic rate of glucose for clinical application using positron emission tomography and 18F-fluoro-2-deoxy-D-glucose.
Topics: Algorithms; Brain; Brain Chemistry; Brain Neoplasms; Cerebrovascular Circulation; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model.
Topics: Animals; Biomarkers, Tumor; Brain; Brain Neoplasms; Catheters, Indwelling; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Energy Metabolism; Fluorodeoxyglucose F18; Glioma; Immunohistochemistry; Infusion Pumps, Implantable; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Transplantation; Nerve Tissue Proteins; Positron-Emission Tomography; Rats; Rats, Inbred F344; Survival Rate | 2007 |
Defining the spectrum of international practice in pediatric epilepsy surgery patients.
Topics: Adolescent; Age Factors; Age of Onset; Australia; Brain Diseases; Brain Neoplasms; Child; Child, Preschool; Cross-Cultural Comparison; Electrodes, Implanted; Electroencephalography; Epilepsy; Europe; Fluorodeoxyglucose F18; Health Care Surveys; Hemispherectomy; Humans; Magnetic Resonance Imaging; Neurosurgical Procedures; Preoperative Care; Reoperation; Tomography, Emission-Computed, Single-Photon; United States; Vagus Nerve | 2008 |
Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
Topics: Adult; Aged; Aged, 80 and over; Brain Chemistry; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Radiosurgery; Treatment Outcome | 2006 |
Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET.
Topics: Adult; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
Paradoxical imaging findings in cerebral gliomas.
Topics: Adult; Brain Neoplasms; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2008 |
Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas.
Topics: Adult; Aged; Blood Vessels; Brain Neoplasms; Cell Count; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
Metastatic brain lesions may demonstrate photopenia on FDG-PET.
Topics: Aged; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Sugar rush: the early days of molecular imaging.
Topics: Brain Diseases; Brain Neoplasms; Fluorodeoxyglucose F18; History, 20th Century; History, 21st Century; Humans; Positron-Emission Tomography; Radiopharmaceuticals; United Kingdom | 2008 |
Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glioma; Humans; Male; Metabolic Clearance Rate; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2008 |
Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC).
Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neoplasm Staging; Organizations; Phantoms, Imaging; Positron-Emission Tomography; Prognosis; Recurrence; Survival Rate | 2008 |
FDG-PET imaging for the evaluation of antiglioma agents in a rat model.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Fluorodeoxyglucose F18; Glioma; Glucose Transporter Type 1; Immunohistochemistry; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley | 2008 |
99mTc-Tetrofosmin SPECT for the detection of glioma recurrence.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tomography, Emission-Computed, Single-Photon | 2008 |
18F-FDG PET of common enhancing malignant brain tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Simultaneous demonstration of metabolic lesions consistent with Alzheimer disease and brain metastases on FDG-PET imaging.
Topics: Alzheimer Disease; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
Topics: Adult; Brain; Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Oxygen Consumption; Oxygen Radioisotopes; Tomography, Emission-Computed | 1983 |
EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
Topics: Adult; Brain Neoplasms; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Electroencephalography; Fluorine; Fluorodeoxyglucose F18; Glioma; Humans; Intracranial Pressure; Radioisotopes; Radionuclide Imaging; Thalamus; Tomography, X-Ray Computed | 1983 |
Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxy Sugars; Deoxyglucose; Diagnosis, Differential; Fluorine; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radioisotopes; Tomography, Emission-Computed | 1982 |
Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Tomography, Emission-Computed | 1982 |
MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri.
Topics: Adolescent; Blood Glucose; Brain Neoplasms; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Neurologic Examination; Psychosurgery; Temporal Lobe; Tomography, Emission-Computed | 1995 |
Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
Topics: AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Brain Diseases; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, AIDS-Related; Tomography, Emission-Computed | 1995 |
[Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Glycolysis; Humans; Male; Meningioma; Middle Aged; Tomography, Emission-Computed | 1995 |
Positron emission tomographic assessment of cerebral hemocirculation and glucose metabolism in malignant glioma following treatment with intracarotid recombinant human tumor necrosis factor-alpha.
Topics: Astrocytoma; Brain Neoplasms; Carotid Artery, Internal; Cerebral Angiography; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Injections, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Recombinant Proteins; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1995 |
Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Middle Aged; Organotechnetium Compounds; Radioimmunodetection; Sugar Acids; Technetium Tc 99m Pentetate; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Topics: Adult; Aged; Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Male; Methionine; Middle Aged; Neoplasm Proteins; Stereotaxic Techniques; Tomography, Emission-Computed | 1995 |
Clarification of a fractional uptake concept.
Topics: Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1995 |
Brain glucose utilization in band heterotopia: synaptic activity of "double cortex".
Topics: Adult; Blood Glucose; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Child; Choristoma; Deoxyglucose; Dominance, Cerebral; Electroencephalography; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurons; Synaptic Transmission; Tomography, Emission-Computed | 1994 |
PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
PET-FDG of pleomorphic xanthoastrocytoma.
Topics: Adult; Astrocytoma; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Prognosis; Tomography, Emission-Computed | 1995 |
Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Topics: Adult; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Effects of hyperglycemia on FDG uptake in human brain and glioma.
Topics: Adult; Aged; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1994 |
Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
Topics: Animals; Brain; Brain Neoplasms; Deoxyglucose; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Neoplasm Transplantation; Regression Analysis; Tomography, Emission-Computed | 1994 |
Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Child; Combined Modality Therapy; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Survival Rate; Tomography, Emission-Computed | 1994 |
Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Deoxyglucose; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests; Tomography, Emission-Computed; Treatment Outcome | 1993 |
PET, MRI, and epilepsy.
Topics: Brain Neoplasms; Deoxyglucose; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiography; Temporal Lobe; Tomography, Emission-Computed | 1993 |
In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Infant; Male; Medulloblastoma; Pilot Projects; Tomography, Emission-Computed | 1993 |
Glucose consumption in recurrent gliomas.
Topics: Adult; Animals; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Life Tables; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
Topics: Adolescent; Adult; Age Factors; Astrocytoma; Brain Neoplasms; Contrast Media; Deoxyglucose; Drug Combinations; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme.
Topics: Biological Transport, Active; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxyglucose; Fluorodeoxyglucose F18; Glioblastoma; Humans; Image Processing, Computer-Assisted; Survival Analysis; Tomography, Emission-Computed | 1993 |
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Feasibility Studies; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Infant; Lung Neoplasms; Male; Middle Aged; Thoracic Neoplasms; Tomography, Emission-Computed | 1993 |
Brain metastases from non-central nervous system tumors: evaluation with PET.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography.
Topics: Adolescent; Adult; Brain Diseases; Brain Neoplasms; Deoxyglucose; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gliosis; Glucose; Humans; Magnetic Resonance Imaging; Male; Temporal Lobe; Tomography, Emission-Computed | 1993 |
First year experience using the Fischer ZD-Neurosurgical Localizing Unit with particular reference to the development of PET-guided stereotactic biopsy.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Child, Preschool; Clinical Protocols; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurosurgery; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, AIDS-Related; Magnetic Resonance Imaging; Male; Syphilis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1993 |
Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Brain Neoplasms; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiotherapy; Radiotherapy Dosage; Recurrence; Stereotaxic Techniques; Tomography, Emission-Computed | 1993 |
Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Rubidium Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
FDG-PET screening for cerebral metastases in patients with suspected malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Testicular Neoplasms; Tomography, Emission-Computed | 1996 |
Radiation-induced meningioma evaluated with positron emission tomography with fludeoxyglucose F 18.
Topics: Adult; Basal Ganglia Diseases; Brain Neoplasms; Choristoma; Cranial Irradiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Glucose; Humans; Male; Meningeal Neoplasms; Meningioma; Neoplasms, Radiation-Induced; Tomography, Emission-Computed | 1996 |
Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Topics: Brain Neoplasms; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
Topics: Aged; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Meningeal Neoplasms; Meningioma; Methionine; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Parietal Lobe; Tomography, Emission-Computed | 1996 |
Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
Topics: Adolescent; Adult; Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Ganglioglioma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Prognosis; Survival Rate; Tomography, Emission-Computed | 1996 |
Impact of fluorodeoxyglucose positron emission tomography on the clinical management of patients with glioma.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Retrospective Studies; Tomography, Emission-Computed | 1996 |
Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Topics: Blood Glucose; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Image Processing, Computer-Assisted; Meningeal Neoplasms; Meningioma; Methionine; Tomography, Emission-Computed | 1996 |
Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Ependymoma; Epilepsy, Frontal Lobe; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Methionine; Necrosis; Organotechnetium Compounds; Oximes; Radiation Injuries; Technetium Tc 99m Exametazime; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
F-Dopa as an amino acid tracer to detect brain tumors.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Oxygen Radioisotopes; Tomography, Emission-Computed; Water | 1996 |
18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Radionuclide Imaging; Survival Analysis | 1997 |
[PET studies with C-11 ethanol in intratumoral therapy of hepatocellular carcinomas].
Topics: Aged; Blood Glucose; Brain; Brain Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Deoxyglucose; Ethanol; Female; Fluorodeoxyglucose F18; Humans; Injections, Intralesional; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed | 1996 |
The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Topics: Adult; Aged; Amino Acids; Astrocytoma; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Oligodendroglioma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Retrospective Studies; Tomography, Emission-Computed | 1996 |
Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Topics: Adult; Aged; alpha-Methyltyrosine; Amino Acids; Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase | 1997 |
Discrepancies between HMPAO and ECD SPECT imaging in brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Coronary Circulation; Cysteine; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1997 |
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Methyltyrosines; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma.
Topics: Aged; Brain; Brain Neoplasms; Combined Modality Therapy; Deoxyglucose; Diagnosis, Differential; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Meningioma; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Tomography, Emission-Computed | 1997 |
Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine.
Topics: Adolescent; Adult; Aged; Biopsy; Brain; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Reproducibility of Results; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Topics: Adult; Aged; Biopsy, Needle; Brain; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Stereotaxic Techniques; Tomography, Emission-Computed | 1997 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
PET scanning and the human immunodeficiency virus-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fever of Unknown Origin; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Methionine; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Toxoplasmosis, Cerebral | 1997 |
Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.
Topics: Aminoisobutyric Acids; Animals; Autoradiography; Brain Neoplasms; Cycloleucine; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Transplantation; Pentetic Acid; Radiopharmaceuticals; Rats; Rats, Inbred F344; Rats, Inbred WF; Rats, Sprague-Dawley; Time Factors; Tumor Cells, Cultured | 1997 |
Spinal metastases of a high grade astrocytoma visualized with FDG-PET.
Topics: Adult; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, Emission-Computed | 1997 |
[Positron-emission tomography in oncology].
Topics: Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
[Clinical applications of positron-emission tomography in brain pathology].
Topics: Aged; Alzheimer Disease; Brain Diseases; Brain Neoplasms; Epilepsy; Fluorodeoxyglucose F18; Humans; Male; Obsessive-Compulsive Disorder; Radiopharmaceuticals; Schizophrenia; Tomography, Emission-Computed | 1997 |
Detection of unknown occult primary tumors using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Cell Division; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Ki-67 Antigen; Kinetics; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
What's your favorite PET story?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.
Topics: Adult; Animals; Brain Neoplasms; Cerebellum; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Methionine; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Topics: Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Methionine; Middle Aged; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed | 1998 |
Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride.
Topics: Astrocytoma; Blood Glucose; Brain Neoplasms; Cell Division; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Oligodendroglioma; Sensitivity and Specificity; Survival Rate; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
Cerebral gangliogliomas: preoperative grading using FDG-PET and 201Tl-SPECT.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Ganglioglioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1998 |
Preoperative grading of gangliogliomas using FDG PET and Tl-201 SPECT: comments from a nuclear medicine view.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Ganglioglioma; Humans; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapy.
Topics: Acyclovir; Animals; Antiviral Agents; Biological Transport; Brain Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Gliosarcoma; Glucose; Male; Methionine; Prodrugs; Radiopharmaceuticals; Rats; Rats, Inbred F344; Simplexvirus; Thymidine Kinase | 1998 |
Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Male; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Tenascin; Tomography, Emission-Computed | 1998 |
11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
Topics: Adult; Brachytherapy; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Iodine Radioisotopes; Male; Methionine; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
Brain glucose metabolism with [18F]-fluorodeoxyglucose and positron emission tomography before and after surgical resection of epileptogenic cavernous angiomas.
Topics: Brain; Brain Neoplasms; Epilepsy; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Hemangioma, Cavernous; Humans; Magnetic Resonance Imaging; Postoperative Period; Tomography, Emission-Computed | 1997 |
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
Topics: Astrocytoma; Brain; Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenog
Topics: Animals; Blood Volume; Brain Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Fluorodeoxyglucose F18; Humans; Lymphokines; Melanoma; Mice; Neoplasm Proteins; Neovascularization, Pathologic; RNA, Antisense; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Whole-body [18F]FDG PET in the management of metastatic brain tumours.
Topics: Adult; Aged; Blood Glucose; Brain Edema; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Comparative value of thallium and glucose SPECT imaging in childhood brain tumors.
Topics: Brain Neoplasms; Child; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1998 |
Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.
Topics: Animals; Brain Neoplasms; Carboxylic Acids; Cyclobutanes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiation Dosage; Radiopharmaceuticals; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed | 1999 |
F-18 FDG PET scan of a metastatic pineoblastoma.
Topics: Brain Neoplasms; Child, Preschool; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Pineal Gland; Pinealoma; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Effect of radiotherapy on brain glucose metabolism in patients operated on for low grade astrocytoma.
Topics: Adult; Aged; Astrocytoma; Blood Glucose; Brain; Brain Mapping; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1999 |
Use of ridge regression for improved estimation of kinetic constants from PET data.
Topics: Brain Neoplasms; Computer Simulation; Fluorodeoxyglucose F18; Humans; Models, Theoretical; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 1999 |
[Brain metastases of lung cancer: diagnostic accuracy of positron emission tomography with fluorodeoxyglucose (FDG-PET)].
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Preoperative PET activation for assessment of motor cortex area in precentral chondroma.
Topics: Adult; Brain Neoplasms; Chondroma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Motor Cortex; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Topics: Adult; Astrocytoma; Brain; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Necrosis; Oligodendroglioma; Pilot Projects; Radiation Injuries; Radiography; Radiopharmaceuticals; Radiotherapy; Recurrence; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study.
Topics: Brain; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Radiosurgery; Stereotaxic Techniques; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Staging non-small cell lung cancer with whole-body PET.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1999 |
Positron emission tomography using [18F] fluorodeoxyglucose and [11C] l-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors.
Topics: Adolescent; Blood Glucose; Brain; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Child; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Neoplasms, Neuroepithelial; Nerve Tissue Proteins; Prognosis; Radionuclide Imaging | 1999 |
Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Topics: Adult; Brain; Brain Neoplasms; Case-Control Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 1999 |
Gangliogliomas: characterization by registered positron emission tomography-MR images.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Ganglioglioma; Humans; Infant; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Cerebral deafferentiation in operated gliomas as a predictor for malignancy?
Topics: Brain Neoplasms; Carbon Radioisotopes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Attention; Brain; Brain Diseases; Brain Neoplasms; Child; Cranial Irradiation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Leukocyte Count; Male; Mental Processes; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychomotor Performance; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Survivors; Tomography, Emission-Computed | 2000 |
Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.
Topics: Adult; Aged; Brain; Brain Neoplasms; Cell Division; Female; Fluorodeoxyglucose F18; Humans; Idoxuridine; Iodine Radioisotopes; Kidney; Male; Middle Aged; Radionuclide Imaging | 2000 |
[Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose].
Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Huntington Disease; Image Processing, Computer-Assisted; Male; Middle Aged; Models, Biological; Organ Specificity; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2000 |
Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PE.
Topics: Adenoma; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Goiter; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps.
Topics: Adult; Aged; Brain Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2000 |
Evaluation of dissemination studies with FDG whole-body positron emission tomography in patients with suspected metastatic tumours of brain and spine.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Spinal Neoplasms; Tomography, Emission-Computed | 2000 |
FDG-PET detection of primary lung cancer in a patient with an isolated cerebral metastasis.
Topics: Adenocarcinoma; Biopsy; Brain Neoplasms; Bronchoscopy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Specimen Collection; Brain Diseases; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Tomography, Emission-Computed | 2000 |
Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan.
Topics: Adult; Blood Glucose; Brain Mapping; Brain Neoplasms; Cerebral Cortex; Child; Dementia; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Neuroepithelial; Tomography, Emission-Computed | 1998 |
Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with.
Topics: Adult; Astrocytoma; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Methionine; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
FDG-PET as a prognostic factor in high-grade astrocytoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Middle Aged; Neoplasm Staging; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2000 |
Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors.
Topics: Animals; Brain Neoplasms; Cattle; Fluorodeoxyglucose F18; Glioma; Hexokinase; Humans; Isoenzymes; Kinetics; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tomography, Emission-Computed; Tumor Cells, Cultured | 2001 |
Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Software | 2001 |
High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Methyltyrosines; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2001 |
Successful radiosurgical treatment of lesional epilepsy of mesial temporal origin.
Topics: Adult; Brain Neoplasms; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Magnetic Resonance Imaging; Magnetoencephalography; Radiopharmaceuticals; Radiosurgery; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2001 |
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Radiography; Radiosurgery; Recurrence; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Diagnosis of recurrent astrocytoma with fludeoxyglucose F18 PET scanning.
Topics: Adult; Astrocytoma; Brain Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Zinc-65 imaging of rat brain tumors.
Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Carbon Radioisotopes; Chlorides; Fluorodeoxyglucose F18; Glioma; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Zinc Compounds; Zinc Radioisotopes | 2001 |
Acute effects of stereotactic radiosurgery on the kinetics of glucose metabolism in metastatic brain tumors: FDG PET study.
Topics: Aged; Aged, 80 and over; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Lung Neoplasms; Male; Melanoma; Middle Aged; Phosphorylation; Prognosis; Radiopharmaceuticals; Radiosurgery; Tomography, Emission-Computed | 2001 |
Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
Topics: Adolescent; Adult; Biological Transport; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hallucinogens; Humans; Isoquinolines; Kinetics; Male; N-Methyl-3,4-methylenedioxyamphetamine; Radiopharmaceuticals; Receptors, Serotonin; Regression Analysis; Serotonin Antagonists; Substance-Related Disorders; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 2001 |
Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Brain Neoplasms; Carcinoma, Papillary; Databases as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Magnetic Resonance Imaging; MEDLINE; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor.
Topics: Aged; Brain Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Neglect in radial and vertical axes after a unilateral left temporo-occipital lesion.
Topics: Aged; Aged, 80 and over; Agnosia; Aphasia, Wernicke; Apraxia, Ideomotor; Brain Neoplasms; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glioma; Hemianopsia; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Occipital Lobe; Orientation; Perceptual Disorders; Temporal Lobe; Tomography, Emission-Computed | 2001 |
Physiological FDG uptake in the palatine tonsils.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Palatine Tonsil; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed | 2001 |
Localisation of motor areas in brain tumour patients: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation.
Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Contrast Media; Electric Stimulation; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Intraoperative Period; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Prospective Studies; Psychomotor Performance; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Diagnosis and prognosis in neuro-oncology: contribution of positron emission tomography].
Topics: Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Methionine; Neoplasm Recurrence, Local; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Metabolic and electrophysiological validation of functional MRI.
Topics: Adult; Aged; Artifacts; Bias; Brain Mapping; Brain Neoplasms; Electrodiagnosis; Electrophysiology; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Preoperative Care; Psychomotor Performance; Radiopharmaceuticals; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Stereotaxic Techniques; Tomography, Emission-Computed | 2001 |
Guest editorial: the conception of FDG-PET imaging.
Topics: Brain Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Topics: Aged; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, Emission-Computed | 2002 |
Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
Topics: Adult; Aged; Animals; Astrocytoma; Brain Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Phenylalanine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Topics: Brain Diseases; Brain Neoplasms; Carbon Radioisotopes; Diagnosis, Differential; Fluorodeoxyglucose F18; Glioma; Humans; Meningeal Neoplasms; Meningioma; Methionine; Mitotic Index; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[The PET scan in neuro-oncology--indications, differential diagnosis and clinical application].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Child; Child, Preschool; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Positron emission tomography-guided stereotactic brain biopsy.
Topics: Astrocytoma; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Middle Aged; Models, Anatomic; Stereotaxic Techniques; Tomography, Emission-Computed | 1992 |
Positron emission tomography imaging-directed stereotactic neurosurgery.
Topics: Astrocytoma; Biopsy; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Stereotaxic Techniques; Tomography, Emission-Computed | 1992 |
A PET system based on 2-18FDG production with a low energy electrostatic proton accelerator and a dual headed PET scanner.
Topics: Astrocytoma; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1992 |
Positron emission tomography in clinical practice.
Topics: Adult; Brain Neoplasms; Child; Coronary Disease; Deoxyglucose; Epilepsy, Complex Partial; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Tomography, Emission-Computed | 1992 |
FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Topics: Adult; Biological Transport; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Phosphorylation; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Topics: Abdominal Neoplasms; Brain; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Diagnostic Techniques, Surgical; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Necrosis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1992 |
In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Topics: Adult; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Glycolysis; Humans; Lactates; Lactic Acid; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1992 |
Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Topics: Adult; Aged; Analysis of Variance; Autoradiography; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1990 |
Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine.
Topics: Adult; Aged; Blood-Brain Barrier; Brain Neoplasms; Deoxyglucose; Edetic Acid; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Tomography, Emission-Computed; Tyrosine | 1991 |
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Dexamethasone; Epilepsy; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Postoperative Period; Radiation Injuries; Time Factors; Tomography, Emission-Computed | 1991 |
Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
Topics: Adult; Biological Transport; Blood Glucose; Brain; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Cerebral Infarction; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Male; Mathematics; Middle Aged; Phosphorylation; Rhamnose; Tomography, Emission-Computed | 1991 |
Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
Topics: Brain Neoplasms; Carcinoma, Renal Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Kidney Neoplasms; Melanoma; Stereotaxic Techniques; Tomography, Emission-Computed | 1991 |
New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
Topics: Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Regression Analysis; Survival Analysis; Tomography, Emission-Computed | 1991 |
Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
Topics: Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Prognosis; Tomography, Emission-Computed | 1991 |
Effect of chemotherapy on glioma metabolism.
Topics: Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans | 1991 |
Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Child; Child, Preschool; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Radiography; Radiotherapy; Tomography, Emission-Computed; Vitamin U | 1991 |
Use of relocatable stereotactic frame to integrate positron emission tomography and computed tomography images: application in human malignant brain tumours.
Topics: Antigens, Surface; Biomarkers, Tumor; Biopsy; Blood Glucose; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans; Ki-67 Antigen; Lymphoma; Models, Anatomic; Stereotaxic Techniques; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1990 |
Complementary roles of PET and MR spectroscopy in the management of brain tumors.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Tomography, Emission-Computed | 1990 |
Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Tomography, Emission-Computed | 1990 |
Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phosphorus; Tomography, Emission-Computed | 1990 |
Cerebral diaschisis in patients with malignant glioma.
Topics: Brain; Brain Neoplasms; Cerebrovascular Circulation; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Humans; Tomography, Emission-Computed | 1990 |
Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
Topics: Alzheimer Disease; Brain; Brain Diseases; Brain Neoplasms; Deoxyglucose; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Radiation Injuries; Tomography, Emission-Computed | 1990 |
[Assessment of local cerebral glucose utilization and protein synthesis in a rat brain tumor model. Simultaneous measurement by quantitative double-racer autoradiography].
Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Protein Biosynthesis; Rats; Rats, Inbred Strains; Valine | 1988 |
[Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET].
Topics: Adolescent; Adult; Antineoplastic Agents; Brain; Brain Neoplasms; Carbon Radioisotopes; Cerebrovascular Circulation; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Nimustine; Oxygen Radioisotopes; Tegafur; Tomography, Emission-Computed | 1989 |
Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Topics: Astrocytoma; Brain; Brain Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Tomography, Emission-Computed | 1989 |
[Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning].
Topics: Adenosine Triphosphate; Adult; Blood Glucose; Brain Neoplasms; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glioma; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Phosphocreatine; Phosphorus; Tomography, Emission-Computed | 1989 |
[Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain Edema; Brain Neoplasms; Cerebrovascular Circulation; Child; Child, Preschool; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Hemodynamics; Humans; Male; Meningioma; Middle Aged; Oxygen Consumption; Tomography, Emission-Computed | 1989 |
Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma.
Topics: Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioblastoma; Glucose; Humans; Male; Middle Aged; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1987 |
PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Topics: Astrocytoma; Brachytherapy; Brain Neoplasms; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Radiation Injuries; Rubidium Radioisotopes; Tomography, Emission-Computed | 1988 |
Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
Topics: Adult; Aged; Brain; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Tomography, Emission-Computed | 1986 |
Prediction of survival in glioma patients by means of positron emission tomography.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Middle Aged; Radiography; Radioisotopes; Tomography, Emission-Computed | 1985 |
[In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Cerebrovascular Circulation; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioblastoma; Glioma; Glucose; Humans; Male; Middle Aged; Oligodendroglioma; Oxygen Consumption; Oxygen Radioisotopes; Tomography, Emission-Computed | 1986 |
Oxidative metabolism and glycolysis in benign brain tumors.
Topics: Brain Neoplasms; Deoxyglucose; Electron Transport Complex IV; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hexokinase; Humans; Mitochondria; NADH Dehydrogenase; Oxygen Consumption | 1987 |
Heterogeneity of regional cerebral glucose metabolism demonstrated in situ in rat brain by 19F NMR rotating frame zeugmatography: one dimensional chemical shift imaging of normal and gliosarcoma implanted brain.
Topics: Aldehyde Reductase; Animals; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Magnetic Resonance Spectroscopy; Male; Pentose Phosphate Pathway; Rats; Rats, Inbred Strains; Sorbitol | 1987 |
Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Carmustine; Child; Child, Preschool; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy; Tomography, Emission-Computed | 1988 |
Positron emission tomography in patients with glioma. A predictor of prognosis.
Topics: Adult; Aged; Brain Neoplasms; Deoxy Sugars; Deoxyglucose; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Middle Aged; Pilot Projects; Prognosis; Tomography, Emission-Computed | 1988 |
PET quantitation: blessing and curse.
Topics: Brain Neoplasms; Data Interpretation, Statistical; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1988 |
Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Topics: Adolescent; Adult; Aged; Biological Transport; Brain; Brain Neoplasms; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Phosphorylation; Tomography, Emission-Computed | 1988 |
Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.
Topics: Blood Glucose; Blood-Brain Barrier; Brain Neoplasms; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Kinetics; Metabolic Clearance Rate; Models, Cardiovascular; Tomography, Emission-Computed | 1986 |
[An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
Topics: Brain Neoplasms; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Radioisotopes; Tomography, Emission-Computed | 1986 |
Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
Topics: Blood-Brain Barrier; Brain Neoplasms; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Prognosis; Radioisotopes; Tomography, Emission-Computed | 1987 |
Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Topics: Adult; Brain; Brain Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Thiopental; Tomography, Emission-Computed | 1987 |
Comparative analysis of regional brain blood flow and glucose metabolism in focal cerebrovascular disease measured by dynamic positron emission tomography of fluorine-18-labelled tracers.
Topics: Adult; Aged; Brain; Brain Ischemia; Brain Neoplasms; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Hemangioma; Humans; Male; Middle Aged; Parietal Lobe; Regional Blood Flow; Tomography, Emission-Computed | 1987 |
Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Neoplasms; Cerebellum; Cerebral Infarction; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Sense Organs; Sensory Deprivation; Tomography, Emission-Computed | 1987 |
[Tomographic mapping of rate constants of [F-18] FDG model].
Topics: Brain; Brain Neoplasms; Cerebral Infarction; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Glioma; Humans; Kinetics; Models, Biological; Radioisotopes; Tomography, Emission-Computed | 1985 |
Brain imaging of glucose utilization in cerebral tumors.
Topics: Adult; Aged; Brain Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1985 |
Regional glucose utilization and blood flow in experimental brain tumors studied by double tracer autoradiography.
Topics: Animals; Antipyrine; Autoradiography; Brain Neoplasms; Carbon Radioisotopes; Deoxy Sugars; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Kinetics; Radioisotopes; Rats; Regional Blood Flow | 1985 |